10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 30, 2022
	or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________to _______________.

Commission File Number: 001-38608

WISA Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware	30-1135279
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

15268 NW Greenbrier Pkwy

Beaverton, OR 97006

(Address of principal executive offices) (Zip Code)

(408) 627-4716

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001 per share	WISA	The Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ☐	Accelerated filer  ☐
Non-accelerated filer  ☒	Smaller reporting company  ☒
	Emerging growth company  ☒

If an emerging growth company, indicate by check-mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐    No  ☒

The number of shares of the registrant’s common stock outstanding as of November 16, 2022 is 17,119,353.

WISA TECHNOLOGIES, INC.

QUARTERLY REPORT ON FORM 10-Q

For the quarter ended September 30, 2022

	Page  Number
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Operations	4
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)	5
Condensed Consolidated Statements of Cash Flows	6
Notes to Condensed Consolidated Financial Statements	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3. Quantitative and Qualitative Disclosures About Market Risk	33
Item 4. Controls and Procedures	33
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	34
Item 1A. Risk Factors	34
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3. Defaults Upon Senior Securities	34
Item 4. Mine Safety Disclosures	34
Item 5. Other Information	34
Item 6. Exhibits	35
SIGNATURES	36

2

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements

WISA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

	September 30, 2022		December 31, 2021
	(unaudited)		(1)
Assets
Current Assets:
Cash and cash equivalents	$	2,644	$	13,108
Accounts receivable		237		214
Inventories		7,284		4,780
Prepaid expenses and other current assets		1,033		1,086
Total current assets		11,198		19,188
Property and equipment, net		198		162
Other assets		174		41
Total assets	$	11,570	$	19,391
Liabilities, Convertible Preferred Stock and Stockholders’ Equity
Current Liabilities:
Accounts payable	$	2,623	$	1,549
Accrued liabilities		1,239		1,416
Total current liabilities		3,862		2,965
Convertible notes payable, net		1,277		—
Derivative liability		286		—
Warrant liability		719		8
Other liabilities		74		41
Total liabilities		6,218		3,014
Commitments and contingencies (Note 8)
Series A 8% Senior Convertible Preferred stock, par value $0.0001; 0 shares authorized and outstanding as of September 30, 2022; 1,250,000 shares authorized; 0 shares outstanding as of December 31, 2021(liquidation preference of $0)		—		—
Stockholders’ Equity:
Common stock, par value $0.0001; 200,000,000 shares authorized; 17,119,353 and 15,819,059 shares outstanding as of September 30, 2022 and December 31, 2021, respectively		2		2
Additional paid-in capital		230,181		228,578
Accumulated deficit		(224,831)		(212,203)
Total stockholders’ equity		5,352		16,377
Total liabilities, convertible preferred stock and stockholders’ equity	$	11,570	$	19,391

(1) The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

WISA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the three and nine months ended September 30, 2022 and 2021

(in thousands, except share and per share data)

(unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Revenue, net	$	937	$	1,807	$	2,449	$	4,541
Cost of revenue		807		1,301		2,069		3,281
Gross profit		130		506		380		1,260
Operating Expenses:
Research and development		1,939		1,322		5,359		3,800
Sales and marketing		1,539		1,021		4,165		2,870
General and administrative		1,400		1,081		3,608		3,037
Total operating expenses		4,878		3,424		13,132		9,707
Loss from operations		(4,748)		(2,918)		(12,752)		(8,447)
Interest expense		(173)		(3)		(174)		(9)
Change in fair value of warrant liability		274		—		274		—
Gain on forgiveness of Paycheck Protection Program loan		—		859		-		859
Other (expense) income		(2)		1		(7)		(6)
Warrant inducement expense		—		—		—		(1,146)
Loss before provision for income taxes		(4,649)		(2,061)		(12,659)		(8,749)
Provision for income taxes		—		—		2		2
Net loss		(4,649)		(2,061)		(12,661)		(8,751)
Convertible preferred stock dividend		—		—		—		(34)
Deemed dividend on exchange of convertible preferred stock for common stock		—		—		—		(1,192)
Net loss attributable to common stockholders	$	(4,649)	$	(2,061)	$	(12,661)	$	(9,977)
Net loss per common share - basic and diluted	$	(0.31)	$	(0.15)	$	(0.85)	$	(0.86)
Weighted average number of common shares used in computing net loss per common share		15,070,489		13,917,295		14,975,121		11,600,875

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

WISA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

For the three and nine months ended September 30, 2022 and 2021

(in thousands, except share and per share data)

(unaudited)

											Total
	Convertible Preferred Stock			Common Shares			Additional		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Paid-in Capital		Deficit		Equity
Balance as of December 31, 2021	—		—	15,819,059	$	2	$	228,578	$	(212,203)	$	16,377
ASC 842 adoption adjustment	—		—	—		—		—		33		33
Stock-based compensation	—		—	1,067,400		—		480		—		480
Release of vested restricted common stock	—		—	5,668		—		—		—		—
Restricted stock awards cancelled	—		—	(8,663)		—		—		—		—
Net loss	—		—	—		—		—		(3,904)		(3,904)
Balance as of March 31, 2022	—		—	16,883,464	$	2	$	229,058	$	(216,074)	$	12,986
Stock-based compensation	—		—	30,000		—		506		—		506
Release of vested restricted common stock	—		—	1,167		—		—		—		—
Restricted stock awards cancelled	—		—	(14,809)		—		—		—		—
Net loss	—		—	—		—		—		(4,108)		(4,108)
Balance as of June 30, 2022	—		—	16,899,822		2		229,564		(220,182)		9,384
Stock-based compensation	—		—	177,500		—		526		—		526
Release of vested restricted common stock	—		—	59,931		—		—		—		—
Restricted stock awards cancelled	—		—	(17,900)		—		—		—		—
Issuance of warrants in connection with convertible promissory note	—		—	—		—		91		—		91
Net loss	—		—	—		—		—		(4,649)		(4,649)
Balance as of September 30, 2022	—		—	17,119,353	$	2	$	230,181	$	(224,831)	$	5,352

	Convertible Preferred Stock			Common Shares			Additional		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Paid-in Capital		Deficit		Equity
Balance as of December 31, 2020	250,000	$	597	8,402,250	$	1	$	207,698	$	(200,383)	$	7,316
Issuance of common stock upon warrant exercise	—		—	2,086,251		—		5,095		—		5,095
Warrants issued in connection with warrant exercise	—		—	—		—		567		—		567
Convertible preferred stock dividend	—		20	—		—		(20)		—		(20)
Stock-based compensation	—		—	643,700		—		254		—		254
Release of vested restricted common stock	—		—	352		—		—		—		—
Net loss	—		—	—		—		—		(3,292)		(3,292)
Balance as of March 31, 2021	250,000		617	11,132,553		1		213,594		(203,675)		9,920
Issuance of common stock upon warrant exercise	—		—	1,360,244		—		3,159		—		3,159
Warrants issued in connection with warrant exercise	—		—	—		—		579		—		579
Convertible preferred stock dividend	—		14	—		—		(14)		—		(14)
Exchange of convertible preferred stock for common stock	(250,000)		(631)	250,000		—		1,640		—		1,640
Warrants issued upon exchange of preferred stock for common stock	—		—	—		—		570		—		570
Deemed dividend on exchange of convertible preferred stock	—		—	—		—		(1,192)		—		(1,192)
Stock-based compensation	—		—	10,000		—		335		—		335
Issuance of common stock to vendor	—		—	10,000		—		34		—		34
Net loss	—		—	—		—		—		(3,398)		(3,398)
Balance as of June 30, 2021	—		—	12,762,797		1		218,705		(207,073)		11,633
Stock-based compensation	—		—	320,800		—		349		—		349
Release of vested restricted common stock	—		—	201,343		—		-		—		—
Issuance of common stock upon warrant exercise	—		—	19,000		—		49		—		49
Registered direct offering, net of issuance costs	—		—	2,500,000		1		9,025		—		9,026
Net loss	—		—	—		—		—		(2,061)		(2,061)
Balance as of September 30, 2021	—	$	—	15,803,940	$	2	$	228,128	$	(209,134)	$	18,996

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

WISA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the nine months ended September 30, 2022 and 2021

(in thousands, except share and per share data)

(unaudited)

	Nine Months Ended September 30,
	2022		2021
Cash flows from operating activities:
Net loss	$	(12,661)	$	(8,751)
Adjustments to reconcile net loss to net cash used in operating activities:
Warrant inducement expense		—		1,146
Forgiveness of Paycheck Protection Program loan		—		(859)
Stock-based compensation		1,512		938
Depreciation and amortization		91		59
Expense for issuance of common stock for services		—		34
Amortization of debt discounts		156		—
Change in fair value of warrant liability		(274)		—
Changes in operating assets and liabilities:
Accounts receivable		(23)		(120)
Inventories		(2,504)		(1,246)
Prepaid expenses and other assets		53		(572)
Other assets		79		—
Accounts payable		1,074		153
Accrued liabilities		(288)		644
Other liabilities		(111)		—
Net cash used in operating activities		(12,896)		(8,574)
Cash flows from investing activities:
Purchases of property and equipment		(36)		(86)
Net cash used in investing activities		(36)		(86)
Cash flows from financing activities:
Proceeds from issuance of common stock upon warrant exercises, net of issuance costs		—		8,303
Proceeds from issuance of convertible notes payable, net of issuance costs		2,483		—
Repayment of capital lease		(15)		(17)
Proceeds from issuance of common stock, in registered direct offering, net of issuance costs		—		9,026
Net cash provided by financing activities		2,468		17,312
Net (decrease) increase in cash and cash equivalents		(10,464)		8,652
Cash and cash equivalents as of beginning of period		13,108		7,415
Cash and cash equivalents as of end of period	$	2,644	$	16,067
Supplemental disclosure of cash flow information:
Cash paid for interest	$	17	$	3
Cash paid for income taxes	$	2	$	2
Noncash Investing and Financing Activities:
Issuance of warrants in connection with convertible notes payable	$	1,076	$	—
Derivative liability recorded in connection with issuance of convertible notes payable	$	286
Exchange of convertible preferred stock for common stock	$	—	$	1,640
Deemed dividend on exchange of convertible preferred stock for common stock	$	—	$	(1,192)
Issuance of warrants in connection with exchange of preferred stock	$	—	$	570
Convertible preferred stock dividend	$	—	$	34

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies

WiSA Technologies, Inc formerly known as Summit Wireless Technologies, Inc. (together with its subsidiaries also referred to herein as “we”, “us”, “our”, or the “Company”) was originally formed as a limited liability company in Delaware on July 23, 2010. Our business is to deliver the best-in-class immersive wireless sound technology for intelligent devices and next generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.

NASDAQ Notifications

On June 23, 2022, the Company received a written notification (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), because the closing bid price of the Company’s common stock was below $1.00 per share for the previous thirty (30) consecutive business days. The Notice has no immediate effect on the listing of the common stock, which will continue to trade uninterrupted on the Nasdaq Capital Market under the ticker “WISA.”

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted 180 calendar days from the date of the Notice, or until December 20, 2022 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Requirement. If at any time during the Compliance Period, the bid price of the common stock closes at or above $1.00 per share for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company with written confirmation of compliance with the Minimum Bid Price Requirement and the matter will be closed.

Strategic Advisor

During the third quarter of 2022, the Company retained a strategic advisor to explore strategic opportunities specifically involving the Company’s IP. Potential strategic opportunities that may be explored or evaluated as part of this process include the potential for capital raising transactions, an acquisition, sale of assets, including substantially all of the Company’s assets, merger, business combination, partnership, joint venture, licensing and/or another strategic alternative. Despite the Company’s efforts to identify and evaluate potential strategic transactions, the process may not result in any definitive offer to consummate a strategic transaction, or, if we receive such a definitive offer, the terms may not be as favorable as anticipated or may not result in the execution or approval of a definitive agreement.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to Article 10 of Regulation S-X of the Securities Act of 1933, as amended (“Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include all normal and recurring adjustments that the Company believes are necessary to fairly state the Company’s financial position and the results of operations and cash flows. Interim period results are not necessarily indicative of results of operations or cash flows for a full year or any subsequent interim period. The condensed consolidated balance sheet as of December 31, 2021 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

7

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies, continued

Reclassification

Certain reclassifications have been made to prior periods’ condensed consolidated financial statements to conform to the current period presentation. These reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts at one financial institution. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition as necessary, and sometimes requires partial payment in advance of shipping. As of September 30, 2022 and December 31, 2021, there was no allowance for doubtful accounts. As of September 30, 2022, the Company had two customers accounting for 61%, and 12% of accounts receivable. As of December 31, 2021, the Company had two customers accounting for 35%, and 27% of accounts receivable.

The Company had three customers accounting for 42%, 16% and 12% of its net revenue for the three months ended September 30, 2022. The Company had three customers accounting for 20%, 18%, and 16% of its net revenue for the nine months ended September 30, 2022. The Company had three customers accounting for 63%, 12% and 12% of its net revenue for the three months ended September 30, 2021. The Company had three customers accounting for 33%, 17%, and 10% of its net revenue for the nine months ended September 30, 2021.

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships, dependence on key individuals, and the uncertainties related to supply chain disruptions for customers and suppliers as well as the impact that inflation may have on consumer purchasing and the economy as a whole.

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chip and a single contractor in China for the production of its receive semiconductor chip.

Deferred Offering Costs

Deferred offering costs, consisting of legal, accounting and filing fees relating to public offerings, are capitalized. The deferred offering costs will be offset against public offering proceeds upon the effectiveness of an offering. In the event that an offering is terminated, deferred offering costs will be expensed. As of September 30, 2022 and December 31, 2021, the Company had capitalized $206,000 and $83,000 respectively, of deferred offering costs in prepaid expenses and other current assets on the condensed consolidated balance sheet.

8

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies, continued

Convertible Financial Instruments

The Company bifurcates conversion options and warrants from their host instruments and accounts for them as freestanding derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

When the Company has determined that the embedded conversion options and warrants should be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.

Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or their earliest date of redemption.

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for shares of common stock and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its warrants for shares of common stock and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

In an equity-classified freestanding financial instrument, as of the date that a down round feature is triggered, the Company measures the fair value of the instrument without the down round feature (that is, before the strike price is reduced) and the fair value of the financial instrument with a strike price that reflects the adjustment from the down round. The incremental difference in the fair value is recorded a deemed dividend. As the Company has an accumulated deficit, the deemed dividend is recorded as a reduction of additional paid-in capital in the condensed consolidated balance sheet. The Company increases the net loss available to common stockholders by the amount of the deemed dividend.

Product Warranty

The Company’s products are generally subject to a one-year warranty, which provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within the stated specification. The Company has assessed its historical claims and, to date, product warranty claims have not been significant. The Company will continue to assess if there should be a warranty accrual going forward.

9

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies, continued

Revenue Recognition

The Company generates revenue primarily from two product categories which include the sale of Consumer Audio Products as well as the sale of Components. The Company applies the following five steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company considers customer purchase orders to be the contracts with a customer. Revenues, net of expected discounts, are recognized when the performance obligations of the contract with the customer are satisfied and when control of the promised goods are transferred to the customer, typically when products, which have been determined to be the only distinct performance obligations, are shipped to the customer. Expected costs of assurance warranties and claims are recognized as expense.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components.

Sales to certain distributors are made under arrangements which provide the distributors with price adjustments, price protection, stock rotation and other allowances under certain circumstances. The Company does not provide its customers with a contractual right of return. However, the Company accepts limited returns on a case-by-case basis. These returns, adjustments and other allowances are accounted for as variable consideration. We estimate these amounts based on the expected amount to be provided to customers and reduce revenue recognized. We believe that there will not be significant changes to our estimates of variable consideration.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those amounts are classified as contract liabilities which are included in other current liabilities when the payment is made or it is due, whichever is earlier.

During the three and nine months ended September 30, 2022 and 2021, net revenue consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Components	$	696	$	1,632	$	1,769	$	3,949
Consumer Audio Products		241		175		680		592
Total	$	937	$	1,807	$	2,449	$	4,541

10

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies, continued

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of September 30, 2022 and December 31, 2021.

	September 30,		December 31,
(in thousands)	2022		2021
Contract liabilities	$	32	$	—

Revenue by Geographic Area

In general, revenue disaggregated by geography (See Note 10) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.

Practical Expedients and Exemptions

As part of our adoption of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, we elected to use the following practical expedients: (i) not to adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less; (ii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less; (iii) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

In addition, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Stock-Based Compensation

The Company measures and recognizes the compensation expense for restricted stock units and restricted stock awards granted to employees and directors based on the fair value of the award on the grant date.

Restricted stock units give an employee an interest in Company stock but they have no tangible value until vesting is complete. Restricted stock units and restricted stock awards are equity classified and measured at the fair market value of the underlying stock at the grant date and recognized as expense over the related service or performance period. The Company elected to account for forfeitures as they occur. The fair value of stock awards is based on the quoted price of our common stock on the grant date. Compensation cost for restricted stock units and restricted stock awards is recognized using the straight-line method over the requisite service period.

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and nine months ended September 30, 2022 were $300,000 and $704,000, respectively. Advertising costs for the three and nine months ended September 30, 2021 were $152,000 and $451,000, respectively.

11

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies, continued

Comprehensive Loss

Comprehensive loss represents the changes in equity of an enterprise, other than those resulting from stockholder transactions. Accordingly, comprehensive loss may include certain changes in equity that are excluded from net loss. For the three and nine months ended September 30, 2022 and 2021, the Company’s comprehensive loss is the same as its net loss.

Foreign Currency

The financial position and results of operations of the Company’s foreign operations are measured using currencies other than the U.S. dollar as their functional currencies. Accordingly, for these operations all assets and liabilities are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Expense items are translated using the weighted average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these operations’ financial statements are reported as a separate component of stockholders’ equity, while foreign currency transaction gains or losses, resulting from re-measuring local currency to the U.S. dollar are recorded in the condensed consolidated statement of operations in other income (expense), net and were not material for the three and nine months ended September 30, 2022 and 2021.

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive common share equivalents outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per common share calculation, Series A Preferred Stock, warrants exercisable for common stock, restricted stock units and shares issuable upon the conversion of convertible notes payable are considered to be potentially dilutive securities.

As of September 30, 2022, warrants to purchase 6,702,802 shares of common stock, 1,677,484 shares of restricted stock, 290,625 shares of restricted stock issued under an inducement grant and 731,627 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

As of September 30, 2021, warrants to purchase 4,475,424 shares of common stock, 711,805 shares of restricted stock, 310,000 shares of restricted stock issued under an inducement grant and 456,931 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

Recently Adopted Accounting Pronouncements

Adoption of Accounting Standards Codification (“ASC”) 842

The Company adopted Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2016-02, Leases (“Topic 842”), as of January 1, 2022, using the modified retrospective approach. The modified retrospective approach provides a method for recording existing leases at the beginning of the period of adoption. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to carry forward the historical lease classification and the Company elected the hindsight practical expedient to determine the lease term for existing leases.

12

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

1. Business and Summary of Significant Accounting Policies, continued

Adoption of the new standard resulted in the recording of operating lease right-of-use assets of $212,000 and lease liabilities of $327,000, as of January 1, 2022. In addition, the new standard resulted in the recording of an additional $90,000 of property and equipment and the reversal of $58,000 of deferred rent and lease incentive as required under the new standard. The standard did not have an impact on our consolidated results of operations or cash flows. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.

The effect of the changes made to our consolidated January 1, 2022 balance sheet for the adoption of the new lease standard was as follows (in thousands):

	Balance as of		Adjustments		Balance as of
	December 31, 2021		Due to ASC 842		January 1, 2022
Operating lease right-of-use assets	$	—	$	212	$	212
Property and equipment, net		162		90		252
Total assets	$	19,391	$	302	$	19,693
Operating lease liabilities, current	$	—	$	148	$	148
Operating lease liabilities, non-current	$	—	$	179	$	179
Deferred rent and lease incentive	$	58	$	(58)	$	—
Total liabilities	$	3,014	$	269	$	3,283
Accumulated deficit	$	(212,203)	$	33	$	(212,170)
Total stockholders’ equity	$	16,377	$	33	$	16,410
Total liabilities and stockholders’ equity	$	19,391	$	302	$	19,693

Recently Issued and Not Yet Adopted Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06 “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. As an emerging growth company, the Company is allowed to adopt the accounting pronouncement at the same time as non-public business entities. As a result, the Company will adopt the update for its fiscal year beginning after December 15, 2023. The Company is evaluating the impact of this standard on its condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, as amended, which requires the early recognition of credit losses on financing receivables and other financial assets in scope. ASU 2016-13 requires the use of a transition model that will result in the earlier recognition of allowances for losses. The new standard is effective for fiscal years beginning after December 15, 2022. Management is currently evaluating the new standard and its possible impact on the Company’s condensed consolidated financial statements.

We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.

13

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

2. Going Concern

The condensed consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. The Company has incurred net operating losses each year since inception. As of September 30, 2022, the Company had cash and cash equivalents of $2.6 million and reported net cash used in operations of $12.9 million during the nine months ended September 30, 2022. In August of 2022, the Company raised net proceeds of $2.5 million from the issuance of a $3.6 million convertible notes payable. In September 2022, the Company entered into an “at-the-market” sales agreement with Maxim and no proceeds have yet been generated by the sales agreement. The Company expects operating losses to continue in the foreseeable future because of additional costs and expenses related to research and development activities, plans to expand its product portfolio, and costs associated with efforts to increase its market share. The Company’s ability to transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support its cost structure.

Based on current operating levels, the Company will need to raise additional funds by selling additional equity or incurring additional debt. To date, the Company has funded its operations primarily through sales of its common stock in public markets, sales of common and preferred units prior to its initial public offering (“IPO”) proceeds from the exercise of warrants to purchase common stock and the sale of convertible notes and issuance of convertible notes payable. Additionally, future capital requirements will depend on many factors, including the rate of revenue growth, the selling price of the Company’s products, the expansion of sales and marketing activities, the timing and extent of spending on research and development efforts and the continuing market acceptance of the Company’s products. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months from the date of this report.

Management of the Company intends to raise additional funds through the issuance of equity securities or debt. There can be no assurance that, in the event the Company requires additional financing, such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending could have a material adverse effect on the Company’s ability to achieve its intended business objectives. As a result, the substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

14

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

3. Balance Sheet Components

Inventories (in thousands):

	September 30,		December 31,
	2022		2021
Raw materials	$	3,116	$	2,676
Work in progress		452		784
Finished goods		3,716		1,320
Total inventories	$	7,284	$	4,780

Property and equipment, net (in thousands):

	September 30,		December 31,
	2022		2021
Machinery and equipment	$	992	$	965
Tooling		11		11
Computer software		—		89
Furniture and fixtures		15		15
Leasehold improvements		127		40
		1,145		1,120
Less: Accumulated depreciation and amortization		(947)		(958)
Property and equipment, net	$	198	$	162

Depreciation and amortization expense for the three months ended September 30, 2022 and 2021 was $31,000 and $20,000, respectively. Depreciation and amortization expense for the nine months ended September 30, 2022 and 2021 was $91,000 and $59,000, respectively.

The cost and accumulated depreciation of assets acquired under finance lease included in machinery and equipment in the above table as of September 30, 2022 were $72,000 and $50,000 respectively.

Accrued liabilities (in thousands):

	September 30,		December 31,
	2022		2021
Accrued rebate	$	417	$	356
Accrued vacation		401		385
Lease liability		142		—
Accrued audit fees		140		191
Customer advances		32		—
Accrued compensation		—		231
Accrued other		107		253
Total accrued liabilities	$	1,239	$	1,416

15

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

4. Borrowings

Convertible Promissory Note

On August 15, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and between the Company and an institutional investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a senior secured convertible note in the principal amount of $3,600,000 (the “Convertible Note”) and a warrant (the “Warrant”) to purchase up to 2,097,022 shares of the Company’s common stock, at an exercise price of $0.997 per share (the “Exercise Price”), in consideration for $3,000,000. Pursuant to the Purchase Agreement, upon the closing of the private placement of the Convertible Note and Warrant, pursuant to which Maxim acted as placement agent (the “Private Placement”), the Company received gross proceeds of $3,000,000. After the deduction of banker fees, commitment fees and other expenses associated with the transaction, the Company received net proceeds of $2,483,000. The Company intends to use the net proceeds primarily for working capital and general corporate purposes.

The Convertible Note matures on August 15, 2024, does not bear interest and ranks senior to the Company’s existing and future indebtedness and is secured to the extent and as provided in the Security Agreements. The Convertible Note is convertible in whole or in part at the option of the Investor into shares of Common stock (the “Conversion Shares”) at the Conversion Price (as defined below) at any time following the date of issuance of the Convertible Note.

The Convertible Note defines “Conversion Price” as equal to the lesser of (a) 90% of the average of the five lowest daily VWAPs (as defined in the Convertible Note) during the previous twenty trading days prior to delivery to the Company of the Investor’s applicable notice of conversion (the “Conversion Notice”) and (b) $0.926 (the “Base Conversion Price”). The Base Conversion Price is subject to full ratchet antidilution protection, subject to a floor conversion price of $0.25 per share (the “Floor Price”), a limitation required by the rules and regulations of Nasdaq, and certain exceptions upon any subsequent transaction at a price lower than the Base Conversion Price then in effect and standard adjustments in the event of stock dividends, stock splits, combinations or similar events; provided that in the event the Conversion Price equals the Floor Price, the Company is required to pay the Investor a cash amount determined pursuant to a formula in the Convertible Note, and provided further that the Floor Price will not apply in the event that the Company obtains Stockholder Approval (as defined in the Purchase Agreement) in accordance with Nasdaq rules. At any time after the closing date of the Private Placement, in the event that the Company issues or sells any shares of common stock or common stock Equivalents (as defined in the Convertible Note), subject to certain exceptions, at an effective price per share lower than the Base Conversion Price then in effect or without consideration, then the Base Conversion Price shall be reduced to the price per share paid for such shares of common stock or common stock Equivalents. Additionally, upon three days’ written notice to the holder after receipt of a Conversion Notice, in lieu of delivering Conversion Shares, the Company has the right to pay the Investor in cash an amount equal to 105% of the portion of the outstanding principal amount stated in such Conversion Notice. Further, at the Investor’s option, the Convertible Note is convertible into shares of common stock or redeemable for 103% of the portion of the outstanding principal amount to be converted in the event that any transaction causes the Conversion Price to be lower than the Floor Price. Subject to certain exceptions, commencing on the Conversion Trigger Date and for a nine-month period after such date, the Investor may convert only up to an aggregate of $250,000 in outstanding principal amount during any calendar month, provided, that if Stockholder Approval has been obtained, the Convertible Note is in default at the time or the Company meets certain capitalization conditions, such conversion limitation would not apply.

The obligations and performance of the Company under the Convertible Note and the Purchase Agreement are secured by: (a) a senior lien granted pursuant to security agreements between the Investor and the Company, on (a) all of the assets of the Company (b) a senior lien granted pursuant to trademark security agreements between the Investor and the Company; (c) a senior lien granted pursuant to a patent security agreement between the Investor and the Company on all of the patent assets of the Company; and (d) a pledge of certain securities pursuant to a pledge agreement between the Investor, the Company (such agreements listed in (a)-(d) above, collectively, the “Security Agreements”). The payment and performance obligations of the Company under the Convertible Note and the Purchase Agreement are guaranteed pursuant to a guaranty by the Company in favor of the Investor.

16

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

4. Borrowings, continued

In connection with the August 2022 Note, the Company issued warrants to the Investor and Maxim to purchase common shares of 2,097,022 and 194,384, respectively (see Note 6 – Fair Value Measurements). The sum of the fair value of the warrants, the original issue discount for interest, issuance costs and the derivative liability for the embedded conversion feature for the August 2022 Notes were recorded as debt discounts totaling $2,479,000 to be amortized to interest expense over the respective term using the effective interest method. During the three months ended September 30, 2022, the Company recognized $156,000 of interest expense from the amortization of debt discounts. As of September 30, 2022 the net unamortized debt discounts totaled $2,323,000 and the net carrying value of the convertible notes payable was $1,277,000.

The August 2022 Note contains several embedded conversion features. The Company also concluded that those conversion features require bifurcation from the Convertible Note and subsequent accounting in the same manner as a freestanding derivative. The Company recognized a derivative liability of $286,000 upon execution of the note agreement and that liability is unchanged at September 30, 2022. Accordingly, subsequent changes in the fair value of these conversion features are measured at each reporting period and recognized in the condensed consolidated statement of operations.

Payroll Protection Program Note Agreement

On May 3, 2020, we received a loan (the “PPP Loan”) from Wells Fargo Bank, National Association in the aggregate amount of $847,000, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, which was enacted on March 27, 2020. The PPP Loan was funded on May 7, 2020. The PPP Loan, which is in the form of a PPP promissory note and agreement, dated May 3, 2020 (the “PPP Note Agreement”), had a maturity date of May 3, 2022 and bore interest at a rate of 1.00% per annum. Pursuant to a change in guidance by the U.S. Small Business Administration, the initial monthly payment date of the PPP Note Agreement was deferred from November 1, 2020 to August 18, 2021. The PPP Loan could be prepaid by us at any time prior to maturity with no prepayment penalties.

During the third quarter of 2021, the Company received full loan forgiveness for obligations related to the PPP Loan. The Company accounted for the PPP Loan as debt, and the loan forgiveness was accounted for as a debt extinguishment. The amount of loan and interest forgiven totaling $859,000, was recognized as a gain upon debt extinguishment in the three-month period ended September 30, 2021.

5. Fair Value Measurements

The Company measures the fair value of financial instruments using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Each level of input has different levels of subjectivity and difficulty involved in determining fair value.

● Level 1 – Inputs used to measure fair value are unadjusted quoted prices that are available in active markets for the identical assets or liabilities as of the reporting date. Therefore, determining fair value for Level 1 investments generally does not require significant judgment, and the estimation is not difficult.

● Level 2 – Pricing is provided by third-party sources of market information obtained through investment advisors. The Company does not adjust for or apply any additional assumptions or estimates to the pricing information received from its advisors.

● Level 3 – Inputs used to measure fair value are unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions. The determination of fair value for Level 3 instruments involves the most management judgment and subjectivity.

17

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

5. Fair Value Measurements, continued

The Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 by level within the fair value hierarchy, are as follows:

(in thousands)	September 30, 2022
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative liability	$	—	$	—	$	286
Warrant liability		—		—		719
	$	—	$	—	$	1,005

(in thousands)	December 31, 2021
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Warrant liability	$	—	$	—	$	8

There were no transfers between Level 1, 2 or 3 during the three and nine months ended September 30, 2022 or September 30, 2021.

Warrant Liability

The changes in the fair value of the warrant liability for the three and nine months ended September 30, 2022 were as follows:

			Fair
			Value at
	December 31,		issuance	Change in	September 30,
	2021		date	fair value	2022
Warrant Liability	$	8	985	(274)	$	719

The calculation of the fair value is described in Note 6 – Convertible Preferred Stock and Stockholders’ Equity.

Derivative Liability

As described above, the conversion provisions embedded in the Convertible Note requires bifurcation and measurement at fair value as a derivative. The fair value was calculated using a Monte Carlo simulation to create a distribution of potential market capitalizations and share prices for the Company on a weekly basis over the assumed period, given the various scenarios. The average value of the Convertible Note was discounted to the valuation date to determine a calibrated discount rate so that the fair value of the Convertible Note was $3 million. The value of the Convertible Note was compared with the value of a hypothetical note with no conversion rights in order to determine the fair value of the conversion feature.

18

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

5. Fair Value Measurements, continued

The changes in the fair value of the derivative liability for the three and nine months ended September 30, 2022 were as follows:

			Fair
			Value at
	December 31,		issuance	Change in	September 30,
	2021		date	fair value	2022
Derivative liability	$	—	286	—	$	286

6. Convertible Preferred Stock and Stockholders’ Equity

Series A 8% Senior Convertible Preferred Stock

On April 18, 2019, we entered into a Securities Purchase Agreement, dated as of April 18, 2019, with a an investor (the “Preferred Investor”) (the “Preferred SPA”), pursuant to which we issued 250,000 shares of our Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which shares did have a stated value of $4.00, grant holders the same voting rights as holders of our shares of common stock, and are convertible into shares of our common stock at price of $80.00 per share, subject to a floor price of $30.00 and to adjustment under our Certificate of Designations of the Preferences, Rights and Limitations of the Series A Preferred Stock, in consideration for $1,000,000 (the “Initial Tranche”). The Series A Preferred Stock may be issued in tranches of at least $500,000 and in an aggregate of up to $5 million. In connection with the Initial Tranche, the Company also issued to the Preferred Investor a warrant to purchase 12,756 shares of our common stock.

The Series A Preferred Stock contained an embedded conversion feature that the Company determined is a derivative requiring bifurcation. The fair value of the derivative liability at the issuance of the Series A Preferred Stock was $216,000, which was recorded as a derivative liability with the offset recorded as a discount to the Series A Preferred Stock.

On June 4, 2021, the Company and the Preferred Investor entered into an exchange agreement pursuant to which the Company exchanged with the Preferred Investor, all outstanding shares of Series A Preferred Stock, for 250,000 shares of common stock and warrants to purchase up to 187,500 shares of common stock. In connection with exchange agreement the Company recorded a deemed dividend of $1,192,000. Immediately following the exchange, the Company no longer had a derivative liability or any preferred stock outstanding.

On August 31, 2022, the Company filed an Elimination of Certificate of Designations of the Preferences, Rights and Limitations of the Series A 8% Senior Convertible Preferred Stock (the “Series A Elimination Certificate”) in order to eliminate and cancel all designations, rights, preferences and limitations of the shares of the Series A 8% Preferred Stock. Prior to the filing of the Series A Elimination Certificate, none of the 1,250,000 authorized shares of Series A Preferred Stock were issued and outstanding, and no shares of Series A Preferred Stock were to be issued subject to the Series A Certificate of Designations. The Series A Elimination Certificate became effective upon its filing with the Secretary of State of the State of Delaware.

As of September 30, 2022, there are no shares of preferred stock issued or outstanding.

Common stock

Carve-Out Plan

For the three months ended March 31, 2021, 352 shares of restricted stock issued under the Carve-Out Plan (the “Plan”), were released with an intrinsic value of approximately $2,000. No shares were subsequently issued under the Plan.

19

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

6. Convertible Preferred Stock and Stockholders’ Equity, continued

2018 Long Term Stock Incentive Plan

On January 30, 2018, the Company’s board of directors approved the establishment of the Company’s 2018 Long-Term Stock Incentive Plan (the “LTIP”) and termination of its Carve-Out Plan (the “Plan”). Under the LTIP, the aggregate maximum number of shares of common stock (including shares underlying options) that may be issued under the LTIP pursuant to awards of Restricted Shares or Options will be limited to 15% of the outstanding shares of common stock, which calculation shall be made on the first trading day of each new fiscal year; provided that, in any year no more than 8% of the common stock or derivative securitization with common stock underlying 8% of the common stock may be issued in any fiscal year. Thereafter, the 15% evergreen provision governs the LTIP. For fiscal year 2022, up to 1,265,525 shares of common stock are available for participants under the LTIP.

For the three and nine months ended September 30, 2022, 61,348 and 284,299 shares of restricted stock issued under the LTIP, were released with an intrinsic value of approximately $37,000 and $294,000, respectively. For the three and nine months ended September 30, 2021, 29,064 shares of restricted stock issued under the LTIP, were released with an intrinsic value of approximately $93,000. A summary of activity related to restricted stock awards (excluding the deferred shares) for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
Stock Awards	Shares	Grant Date Fair Value
Non-vested as of January 1, 2022	728,255	$	3.43
Granted	1,274,900	$	1.18
Vested	(284,299)	$	3.07
Forfeited	(41,372)	$	1.92
Non-vested as of September 30, 2022	1,677,484	$	1.82

As of September 30, 2022, the unamortized compensation cost related to the unvested restricted stock awards was approximately $2,374,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 2.2 years.

Inducement Grant

On September 13, 2021, the Company issued 310,000 shares of restricted common stock to Eric Almgren, the Company’s Chief Strategist, as an inducement grant (“September 2021 Inducement Grant”). Such shares were issued outside the Company’s LTIP and 2020 Stock Incentive Plan (the “2020 Stock Plan”). In accordance with the September 2021 Inducement Grant, 77,500 shares will vest monthly over a period of 36 months and the remaining 232,500 will vest in 77,500 increments, upon the achievement of certain company milestones related to the volume weighted average closing price per share of the Company’s common stock, as reported on NASDAQ, for the ten (10) consecutive days in which thresholds of the Company’s market capitalization of $75 million, $100 million and $150 million are achieved. The September 2021 Inducement Grant was valued with an approximate value of $772,000 and will be amortized over 36 months. On August 24, 2022, the September 2021 Inducement Grant’s vesting milestones related to the Company’s market capitalization were revised to $50 million, $75 million and $100 million. This revision was treated as a modification of the original award and the incremental value recorded was not significant. As of September 30, 2022, the unamortized compensation cost related to the unvested September 2021 Inducement Grant was approximately $504,000 which is to be amortized on a straight-line basis over a period of approximately 2.0 years. The Company recorded stock-based compensation of $63,000 and $191,000, respectively, related to this grant for the three and nine months ended September 30, 2022. As of September 30, 2022, 290,625 shares are unvested.

20

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

6. Convertible Preferred Stock and Stockholders’ Equity, continued

2020 Stock Incentive Plan

A summary of activity related to restricted stock units under the Company’s 2020 Stock Plan for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
Stock Units	Shares	Grant Date Fair Value
Non-vested as of January 1, 2022	438,462	$	2.36
Granted	—	$	—
Vested	(66,766)	$	2.43
Forfeited	(10,069)	$	2.27
Non-vested as of September 30, 2022	361,627	$	2.35

As of September 30, 2022, the unamortized compensation cost related to the unvested restricted stock units was approximately $451,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 0.9 years.

For the three and nine months ended September 30, 2022, 59,931 and 66,766 shares of restricted stock issued under the 2020 Stock Plan were released with an intrinsic value of approximately $43,000 and $50,000, respectively. For the three and nine months ended September 30, 2021, 201,343 shares of restricted stock units were released under the 2020 Stock Plan with an intrinsic value of approximately $646,000.

2022 Plan

On June 21, 2022, the board of directors adopted the Company’s Technical Team Retention Plan of 2022 (the “2022 Plan”) and the reservation of an aggregate of 500,000 shares of the Company’s common stock authorized for issuance under the 2022 Plan, subject to stockholder approval. The 2022 Plan authorizes the grant of equity-based compensation, to the Company’s key managers, employees, consultants who provide technical and engineering and related services to the Company, in the form of restricted stock and restricted stock units. On August 19, 2022, the Company held the 2022 Annual Meeting of Stockholders and approved the adoption of the 2022 Plan and the reservation of an aggregate of 500,000 shares of the Company’s common stock. On September 19, 2022, the Company granted, an aggregate of 370,000 restricted stock units to managers, employees, consultants. Each restricted stock unit represents the right to receive one share of the Company’s common stock under the 2022 Plan.

A summary of activity related to restricted stock units under the Company’s 2022 Plan for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
		Grant Date
Stock Units	Shares	Fair Value
Non-vested as of January 1, 2022	—	$	—
Granted	370,000	$	0.52
Vested	—	$	—
Forfeited	—	$	—
Non-vested as of September 30, 2022	370,000	$	0.52

As of September 30, 2022, the unamortized compensation cost related to the unvested restricted stock units was approximately $191,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 3.7 years.

21

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

6. Convertible Preferred Stock and Stockholders’ Equity, continued

Purchase Agreements

On December 30, 2021, the Company entered into a Sales Agreement with Maxim, pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $4,500,000 from time to time through Maxim. The Company terminated this agreement on September 13, 2022. No shares of common stock were sold under the Sales Agreement.

On September 13, 2022, the Company entered into a 2022 Sales Agreement with Maxim, pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $4,000,000 from time to time through Maxim. No shares of common stock had been sold under the 2022 Sales Agreement as of September 30, 2022.

Warrants for Shares of Common stock

In January 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,221,675 shares of common stock for net proceeds of approximately $2.9 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 305,419 shares of common stock, at an exercise price of $4.20 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $567,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $3.85; expected dividend yield of 0.0%; expected volatility of 60.1%; risk-free interest rate of 0.45% and expected life of 5.0 years.

In June 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,000,000 shares of common stock for net proceeds of approximately $2.3 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 250,000 shares of common stock, at an exercise price of $4.46 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $579,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $4.50; expected dividend yield of 0.0%; expected volatility of 60.7%; risk-free interest rate of 0.77% and expected life of 5.0 years.

In December 2021, the Company granted a warrant to purchase up to 25,000 shares of common stock to Lippert/Heilshorn Associates Inc. The warrant has an exercise price of $1.52 per share and are fully vested. The fair value of the warrant at issuance was $21,000. The fair value of the warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $1.49, expected dividend yield 0%, expected volatility 67%, risk-free interest rate 1.19% and expected life of 5.0 years. The fair value was recorded as professional services with the offset to additional paid-in capital.

In December 2021, the Company granted a warrant to purchase up to 15,000 shares of common stock to Marketing by Design LLC. The warrant has an exercise price of $1.52 per share and are fully vested. The fair value of the warrant at issuance was $12,000. The fair value of the warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $1.49, expected dividend yield 0%, expected volatility 67%, risk-free interest rate 1.19% and expected life of 5.0 years. The fair value was recorded as professional services with the offset to additional paid-in capital.

In connection with the Convertible Note, the Company issued a warrant to the investor to purchase up to 2,097,022 shares of the Company’s common stock, at an exercise price of $0.997 per share (see Note 4 – Borrowings). The grant date fair value of such warrants was $985,000, which was recorded as debt discount with the offset recorded to warrant liability on the condensed consolidated balance sheets. The warrant was recorded as a liability due to the potential variability of its exercise price. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $0.77; expected dividend yield of 0.0%; expected volatility of 80.3%; risk-free interest rate of 2.91% and expected life of 5 years.

22

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

6. Convertible Preferred Stock and Stockholders’ Equity, continued

At September 30, 2022, the fair value of the warrant was $719,000. The Company determined the fair value of the warrant using the Black-Scholes Model based on the following weighted average assumptions: common stock price on revaluation date of $0.56; expected dividend yield of 0.0%; expected volatility of 88.3%; risk-free interest rate of 4.06% and expected life of 4.87 years. The corresponding change in the fair value of the warrant liability of $274,000 was recorded to other income on the condensed consolidated statements of operations.

The Warrant is exercisable immediately and will expire on the fifth (5th) anniversary of its date of issuance and may be exercised on a cashless basis in the event of a fundamental transaction involving the Company or if the resale of the shares of common stock underlying the Warrant is not covered by a registration statement. The Exercise Price is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the Exercise Price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

In connection with the Convertible Note, the Company issued a warrant to Maxim to purchase up to 194,384 shares of the Company’s common stock, at an exercise price of $0.997 per share (see Note 4 – Borrowings). The grant date fair value of such warrants was $91,000, which was recorded as debt discount with the offset recorded to additional paid-in capital on the condensed consolidated balance sheets. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $0.77; expected dividend yield of 0.0%; expected volatility of 80.3%; risk-free interest rate of 2.91% and expected life of 5 years.

The Warrant is exercisable at any time on or after the six-month anniversary of the closing date of the Private Placement and will expire on the fifth (5th) anniversary of its date of issuance and may be exercised on a cashless basis in the event that the shares of common stock underlying the warrant are not covered by a registration statement. In addition, the warrant includes a registration rights provision granting Maxim the same registration rights granted to the Convertible Note investor pursuant to the Purchase Agreement. The exercise price is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

Information regarding warrants for common stock outstanding and exercisable as of September 30, 2022 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	September 30, 2022	Life (years)	September 30, 2022
$1.00 - $2.61	3,938,571	2.92	3,734,187
$3.00 - $4.46	2,446,219	2.88	2,446,219
$6.40 - $9.80	32,889	2.41	32,889
$15.80 - $17.50	92,940	0.50	92,940
$24.80 - $125.00	192,183	0.51	192,183
4.39*	6,702,802	3.47	6,498,418

* Weighted average

Warrants exercisable as of September 30, 2022 exclude warrants to purchase 10,000 shares of common stock issued to a marketing firm, which vest upon the achievement of certain milestones and 204,384 shares of common stock issued to Maxim which will become exercisable on February 15, 2023. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are pre-funded warrants under which the holder must only pay $0.20 per share to complete the exercise.

23

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

6. Convertible Preferred Stock and Stockholders’ Equity, continued

Information regarding warrants for common stock outstanding and exercisable as of December 31, 2021 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	December 31, 2021	Life (years)	December 31, 2021
$1.52 - $3.90	3,537,965	3.56	3,527,965
$4.20 - $9.80	588,308	4.01	588,308
$15.80 - $17.50	92,963	1.06	92,963
$24.80 - $99.00	222,807	1.13	222,807
$108.00 - $125.00	47,678	0.90	47,678
$7.26*	4,489,721	3.44	4,479,721

* Weighted Average

Warrants exercisable as of December 31, 2021 exclude a warrant to purchase 10,000 shares of common stock issued to a marketing consulting firm. Such warrant will vest in two tranches upon the achievement of certain milestones. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are Pre-Funded Warrants under which the holder must only pay $0.20 per share to complete the exercise.

7. Income Taxes

The Company recorded a provision for income taxes of $0 and $2,000 for the three and nine months ended September 30, 2022 and $0 and $2,000 for the three and nine months ended September 30, 2021, respectively.

The Company’s effective tax rate was 0% and (0.02%) for the nine months ended September 30, 2022 and 2021, respectively. The difference between the effective tax rate and the federal statutory tax primarily relates to the valuation allowance on the Company’s deferred tax assets.

For interim periods, the Company estimates its annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company also computes the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim periods in which they occur. The Company also recognizes the effect of changes in enacted tax laws or rates in the interim periods in which the changes occur.

As of September 30, 2022 and December 31, 2021, the Company retains a full valuation allowance on its deferred tax assets. The realization of the Company’s deferred tax assets depends primarily on its ability to generate taxable income in future periods. The amount of deferred tax assets considered realizable in future periods may change as management continues to reassess the underlying factors it uses in estimating future taxable income.

The provision for income taxes for the nine months ended September 30, 2022 and 2021 was calculated on a jurisdiction basis.

24

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

8. Commitments and Contingencies

Operating Leases

The Company leases office space under a non-cancellable operating lease that expires in January 2024 and has an option to renew this lease, with renewal rates to be negotiated. Operating lease rentals are expensed on a straight-line basis over the life of the lease beginning on the date we take possession of the property. At lease inception, we determine the lease term by assuming the exercise of those renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. The lease term is used to determine whether a lease is financing or operating and is used to calculate straight-line rent expense. Additionally, the depreciable life of leasehold improvements is limited by the expected lease term. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.

The following table reflects our lease assets and our lease liabilities at September 30, 2022 (in thousands):

	September 30,		January 1,
	2022		2022
Assets:
Operating lease right-of-use assets	$	143	$	212
Liabilities:
Operating lease liabilities, current	$	142	$	148
Operating lease liabilities, non-current	$	74	$	179

Lease Costs:

The components of lease costs were as follows (in thousands):

	Three Months Ended		Nine Months Ended
	September 30, 2022		September 30, 2022
Operating lease cost	$	28	$	74
Short-term lease cost		9		38
Total lease cost	$	37	$	112

As of September 30, 2022, the maturity of operating lease liabilities was as follows (in thousands):

2022 (remaining 3 months)	$	28
2023		173
2024		29
Total lease payments		230
Less: Interest		(14)
Present value of lease liabilities	$	216

Lease Term and Discount Rate:

	September 30, 2022
Weighted-average remaining lease term (in years)	1.4
Weighted-average discount rate	8.0	%

25

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

8. Commitments and Contingencies, continued

Other Information:

Supplemental cash flow information related to leases was as follows (in thousands):

	Three Months Ended		Nine Months Ended
	September 30, 2022		September 30, 2022
Operating cash outflows from operating leases	$	42	$	125

Finance Lease

During August 2020, the Company entered into a lease agreement for equipment under a capital lease with a term of 36 months. The equipment under the lease is collateral for the agreement and is included within property and equipment, net on the condensed consolidated balance sheets.

Future minimum lease commitments for the finance lease as of September 30, 2022 are as follows (in thousands):

Payments due in:
Year ending December 31, 2022 (remaining 3 months)	$	7
Year ending December 31, 2023		15
Total minimum lease payments		22
Less: Amounts representing interest		(1)
Present value of finance lease obligations		21
Less: Current portion of finance lease liabilities		21
Other liabilities	$	—

Obligations under the finance lease are included in accrued liabilities and other liabilities on the condensed consolidated balance sheets.

Management Team Retention Bonus

On September 1, 2022, the “Company adopted its Management Team Retention Bonus Plan (the “Retention Plan”), to incentivize certain management level employees (the “Managers”) to remain intact through and shortly following a potential “Change of Control” (as defined in the Retention Plan). The aggregate Retention Plan bonus amounts for all Managers is $1,250,000.

The Retention Plan provides that each Manager is eligible to receive a lump sum cash amount under the Retention Plan, on the earlier of the six-month anniversary of the date of a Change of Control or at the time of such Manager’s involuntary termination other than for “Cause” (as defined in the Retention Plan) or termination for “Good Reason” (as defined in the Retention Plan). The Retention Plan will terminate upon the earlier of June 30, 2023 if a Change of Control has not occurred by such date or upon the payment of all Retention Bonus Amounts. As of September 30, 2022, no accrual has been made under the Retention Plan.

26

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

8. Commitments and Contingencies, continued

Contingencies

In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of a possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred.

The Company’s management does not believe that any such matters, individually or in the aggregate, will have a materially adverse effect on the Company’s condensed consolidated financial statements.

9. Related Parties

Helge Kristensen

Mr. Kristensen has served as a member of the Company’s board of directors since 2010. Mr. Kristensen serves as vice president of Hansong Technology, an original device manufacturer of audio products based in China, president of Platin Gate Technology (Nanjing) Co. Ltd, a company with focus on service-branding in lifestyle products as well as pro line products based in China and co-founder and director of Inizio Capital, an investment company based in the Cayman Islands.

For the three months ended September 30, 2022 and 2021, Hansong Technology purchased modules from the Company of approximately $146,000 and $263,000, respectively, and made payments to the Company of approximately $191,000 and $333,000, respectively. For the three months ended September 30, 2022 and 2021, Hansong Technology sold speaker products to the Company of approximately $908,000 and $96,000, respectively, and the Company made payments to Hansong Technology of approximately $516,000 and $309,000, respectively.

For the nine months ended September 30, 2022 and 2021, Hansong Technology purchased modules from the Company of approximately $337,000 and $496,000, respectively, and made payments to the Company of approximately $191,000 and $380,000, respectively. For the nine months ended September 30, 2022 and 2021, Hansong Technology sold speaker products to the Company of approximately $1,367,000 and $854,000, respectively, and the Company made payments to Hansong Technology of approximately $1,306,000 and $962,000, respectively.

At September 30, 2022 and 2021, the Company owed Hansong Technology approximately $851,000 and $96,000, respectively. At September 30, 2022 and 2021, Hansong Technology owed the Company approximately $146,000 and $129,000, respectively.
​

As of September 30, 2022 and December 31, 2021, Mr. Kristensen owned less than 1.0% of the outstanding shares of the Company’s common stock.

David Howitt

Mr. Howitt has served as a member of the Company’s board of directors since December 2021. Mr. Howitt is founder and CEO of Meriwether Group LLC, (“Meriwether”), a strategic consulting firm that works with disruptive consumer brands. Meriwether is the manager of Meriwether Accelerators LLC (“Meriwether Accelerators”).

27

WISA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2022 and 2021

(unaudited)

9.Related Parties, continued

The Company is a party to a professional services agreement with Meriwether Accelerators, dated as of January 15, 2022, pursuant to which, the Company has agreed to pay Meriwether Accelerators (i) $7,500 per month for a period of six months; and (ii) issue 10,000 shares of common stock for each partnership brought to fruition as a result of Meriwether Accelerators’ services and introduction, for up to 40,000 shares of common stock, which shares will have piggyback registration rights, in consideration for certain licensing services and strategic partnership collaborations to be provided by Meriwether Accelerators as set forth in such agreement. For the three and nine months ended September 30, 2022, the Company paid Meriwether Accelerators $8,000 and $45,000, respectively. As of September 30, 2022, the Company has not issued any shares of common stock to Meriwether Accelerators under this agreement nor has it recorded any compensation expense related to the issuance of common stock.

As of September 30, 2022 and December 31, 2021, Mr. Howitt owned less than 1.0% of the outstanding shares of the Company’s common stock.

10. Segment Information

The Company operates in one business segment. Our chief decision-maker, the President and Chief Executive Officer, evaluates our performance based on company-wide consolidated results.

Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue by geographic region for the three and nine months ended September 30, 2022 and 2021 was as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
(in thousands)	2022		2021		2022		2021
North America	$	244	$	166	$	681	$	710
Europe		62		162		411		403
Asia Pacific		631		1,479		1,357		3,428
Total	$	937	$	1,807	$	2,449	$	4,541

Substantially all of our long-lived assets are located in the United States.

28

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Cautionary Notice Regarding Forward Looking Statements

The information contained in Item 2 contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Actual results may materially differ from those projected in the forward-looking statements as a result of certain risks and uncertainties set forth in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (this “Report”). Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual results will not be different from expectations expressed in this Report.

This filing contains a number of forward-looking statements which reflect management’s current views and expectations with respect to our business, strategies, products, future results and events, and financial performance. All statements made in this filing other than statements of historical fact, including statements addressing operating performance, events, or developments which management expects or anticipates will or may occur in the future, and also including statements related to distributor channels, volume growth, revenues, profitability, new products, adequacy of funds from operations, statements expressing general optimism about future operating results, and non-historical information, are forward looking statements. In particular, the words “believe,” “expect,” “intend,” “anticipate,” “estimate,” “may,” variations of such words, and similar expressions identify forward-looking statements, but are not the exclusive means of identifying such statements, and their absence does not mean that the statement is not forward-looking. These forward-looking statements are subject to certain risks and uncertainties, including those discussed below. Our actual results, performance or achievements could differ materially from historical results as well as those expressed in, anticipated, or implied by these forward-looking statements. We do not undertake any obligation to revise these forward-looking statements to reflect any future events or circumstances.

Examples of forward-looking statements include, but are not limited to, statements we make regarding:

● our expectations regarding future trends, expectations, and performance of our business;

● our expectations regarding supply chain disruptions and their impact on our business;

● our expectations about the impact of our strategic plans; and

● the amount and timing of our capital expenditures.

Readers should not place undue reliance on these forward-looking statements, which are based on management’s current expectations and projections about future events, are not guarantees of future performance, are subject to risks, uncertainties and assumptions (including those described below), and apply only as of the date of this filing. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.

Overview

We are an emerging technology company and our primary business focus is to enable mainstream consumers and audio enthusiasts to experience high quality wireless audio. We intend to continue selling our proprietary wireless modules to consumer electronics companies while also expanding our focus to implement a lower cost solution by porting our software onto commercially available internet of things (“IoT”) modules with integrated Wi-Fi technology.

29

Our technology addresses some of the main issues that we perceive are hindering the growth of the home theater: complexity of installation and cost. We believe that consumers want to experience theater quality surround sound from the comfort of their homes. However, wired home theater systems often require expensive audio-visual (“AV”) receivers to decode the audio stream, leaving the consumer with the burden of concealing the wires. Hiring a professional to hide the wires into the walls or floor is invasive, complicated, costly and time consuming. Further, people who rent as opposed to own may not be able to install these systems as the installation construction needed may not be permitted under a lease agreement. Our first-generation wireless technology addresses these problems by transmitting wireless audio to each speaker at Blu-ray quality (uncompressed 24-bit audio up to 96 kHz sample rates) and emphasizing ease of setup. To our knowledge, our custom chips and modules technology is one of the few technologies available today that can stream up to eight (8) separate wireless audio channels with low latency, removing lip-sync issues between the audio and video sources. In addition, every speaker within a system that utilizes our technology can be synchronized to less than one microsecond, thus eliminating phase distortion between speakers. Our first-generation technology shows that wireless home theater systems are viable home audio solutions for the average consumer and audio enthusiast alike.

Current research and development investments focus on developing Wi-Fi compatible software for transmitting multichannel wireless audio for which patent applications have been submitted. A software solution enables smart devices that have Wi-Fi and video media to deliver surround sound audio and allows us to port our wireless audio technology to popular Wi-Fi based modules and systems on a chip (“SOC”) already shipping in volume. The Company’s “Discovery” module announced in January 2021 is the first IoT module solution with our embedded wireless audio software that supports up to four separate wireless audio channels and, we believe, reduces the cost per wireless channel by over 50% for soundbars and entry level home theater applications up to a 3.1 configuration. Our goal is to continue to commercialize and improve performance of a software based-solution, which other brands can integrate into their devices, that will (i) reduce integration costs for mass market use, (ii) utilize Wi-Fi for wireless connectivity, making it easy to integrate into today’s high volume, low cost SOC and modules, (iii) provide a low power consumption option to allow for use in battery powered devices, and (iv) provide compatibility with popular consumer electronic operating systems.

To date, our operations have been funded through sales of our common and preferred equity, proceeds from the exercise of warrants to purchase common stock, sale of debt instruments, and revenue from the sale of our products. Our condensed consolidated financial statements contemplate the continuation of our business as a going concern. However, we are subject to the risks and uncertainties associated with an emerging business, as noted above we have no established source of capital, and we have incurred recurring losses from operations since inception.

Continuing Impacts of the Novel Coronavirus (“COVID-19”) on Our Business and Operations

The COVID-19 pandemic represents a fluid situation that presents a wide range of potential impacts of varying durations for different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.

Given the fact that our products are sold through a variety of distribution channels, we have experienced and we continue to expect that our sales will experience some volatility as a result of the changing and less predictable operational needs of many customers as a result of the COVID -19 pandemic as well as supply chain disruptions and the impacts of inflation. We are aware that many companies, including many of our suppliers and customers, are reporting or predicting negative impacts from COVID -19 on future operating results. To date, we have experienced shipment delays from our suppliers due to COVID -19, which have not had a material adverse impact on our operating results for the quarter ended September 30, 2022. Although we have not directly experienced a material supply interruption, our customers have experienced, and may continue to experience, disruptions in their operations and supply chains as a result of COVID-19, which have resulted, and may in the future result, in delayed, reduced or canceled orders, or collection risks, and which have had, and may in the future have, an adverse effect on our results of operations. There can be no assurance that we will not experience material supply delays or interruptions in the future due to COVID -19.

To date, travel restrictions and border closures have not materially impacted our ability to obtain inventory or manufacture or deliver products or services to customers. However, if such restrictions become more severe, they could negatively impact those activities in a way that would harm our business over the long term. Travel restrictions impacting people can restrain our ability to assist our customers and distributors as well as impact our ability to develop new distribution channels, but at present we do not expect these restrictions on personal travel to be material to our business operations or financial results.

30

Comparison of the Three and Nine Months Ended September 30, 2022 and 2021

Revenue

Revenue for the three months ended September 30, 2022 was $937,000 a decrease of $870,000, or 48%, compared to the revenue for three months ended September 30, 2021 of $1,807,000. The decrease was a result of lower Component revenue which decreased by $936,000, compared to the three months ended September 30, 2021, offset partially by Consumer Audio Product sales which increased by $66,000, compared to the three months ended September 30, 2021. The decrease in Component revenue was due in part to (i) a decrease in demand and (ii) supply chain interruptions experienced by our customers as a result of COVID-19, with their delaying orders to us until other components for their products could be obtained.

Revenue for the nine months ended September 30, 2022 was $2,449,000, a decrease of $2,092,000, or 46%, compared to the revenue for the nine months ended September 30, 2021 of $4,541,000. The decrease was a result of lower Component revenue which decreased by $2,180,000, compared to the nine months ended September 30, 2021, offset partial by Consumer Audio Product sales which increased by $88,000, compared to the nine months ended September 30, 2021. The decrease in Component revenue was due in part to (i) a decrease in demand and (ii) supply chain interruptions experienced by our customers as a result of COVID-19, with their delaying orders to us until other components for their products could be obtained.

Gross Profit and Operating Expenses

Gross Profit

Gross profit for the three months ended September 30, 2022 was $130,000, a decrease of $376,000 compared to $506,000 gross profit for the three months ended September 30, 2021. The decrease in gross profit is mainly attributable to lower volumes of Component sales. The gross margin as a percent of sales was 14% for the three months ended September 30, 2022 compared to 28% for the three months ended September 30, 2021. The decrease in gross margin as a percent of sales is mainly attributable to reduced sales volumes in comparison to the fixed portion of costs included in our manufacturing.

Gross profit for the nine months ended September 30, 2022 was $380,000, a decrease of $880,000 compared to $1,260,000 gross profit for the nine months ended September 30, 2021. The decrease in gross profit is mainly attributable to lower volumes of Component sales. The gross margin as a percent of sales was 16% for the nine months ended September 30, 2022 compared to 28% for the nine months ended September 30, 2021. The decrease in gross margin as a percent of sales is mainly attributable to reduced sales volumes in comparison to the fixed portion of costs included in our manufacturing.

Research and Development

Research and development expenses for the three months ended September 30, 2022 were $1,939,000, an increase of $617,000, compared to the research and development expenses for the three months ended September 30, 2021 of $ 1,322,000. The increase in research and development expenses is primarily related to increased salary and benefit expenses, consulting expenses and stock-based compensation expenses of $325,000, $244,000, and $27,000, respectively.

Research and development expenses for the nine months ended September 30, 2022 were $5,359,000, an increase of $1,559,000 compared to the research and development expenses for the nine months ended September 30, 2021 of $3,800,000. The increase in research and development expenses is primarily related to increased salary and benefit expenses, stock-based compensation expenses, consulting expenses and recruiting expenses $820,000, $79,000, $395,000 and $126,000 respectively.

Sales and Marketing

Sales and marketing expenses for the three months ended September 30, 2022 were $1,539,000, an increase of $518,000, compared to the sales and marketing expenses for the three months ended September 30, 2021 of $1,021,000. The increase in sales and marketing expenses is primarily related to increased salary and benefit expenses, stock-based compensation expenses, consulting expenses, recruiting expenses, tradeshow expenses and advertising expenses of $84,000, $85,000, $57,000, $30,000, $28,000 and $148,000, respectively.

Sales and marketing expenses for the nine months ended September 30, 2022 were $4,165,000, an increase of $1,295,000, compared to the sales and marketing expenses for the nine months ended September 30, 2021 of $2,870,000. The increase in sales and marketing expenses is primarily related to increased salary and benefit expenses, stock-based compensation expenses, consulting expenses, recruiting expenses, and advertising expenses of $365,000, $289,000, $139,000, $30,000 and $251,000, respectively.

31

General and Administrative

General and administrative expenses for the three months ended September 30, 2022 were $1,400,000, an increase of $319,000, compared to the general and administrative expenses for the three months ended September 30, 2021 of $1,081,000. The increase in general and administrative expenses is primarily related to increased stock-based compensation expenses, consulting expenses, accounting fees and legal fees of $65,000, $112,000, $59,000 and $102,000, respectively.

General and administrative expenses for the nine months ended September 30, 2022 were $3,608,000 an increase of $571,000, compared to the general and administrative expenses for the nine months ended September 30, 2021 of $3,037,000. The increase in general and administrative expenses is primarily related increased stock-based compensation expenses, consulting expenses, legal fees and board fees of $218,000, $139,000, $162,000 and $79,000, respectively.

Interest Expense

Interest expense for the three and nine months ended September 30, 2022, was $173,000 and $174,000, respectively. Interest expense for the three and nine months ended September 30, 2022 was primarily due to the amortization of debt discounts associated with the convertible debt that the Company incurred in August 2022. Interest expense for the three and nine months ended September 30, 2021 was not significant.

Change in Fair Value of Warrant Liability

During the three and nine months ended September 30, 2022, there was a gain of $274,000 due to the change in fair value of the warrant liability. The gain was due to the decrease in our common stock price during the period.

There was no change in the fair value of the warrant liability for the three and nine months ended September 30, 2021.

Gain on Forgiveness of Paycheck Protection Loan

The Company recorded a gain of $859,000 due to the forgiveness of the Paycheck Protection Loan for the three and nine months ended September 30, 2021. No such forgiveness occurred during the three and nine months ended September 30, 2022.

Deemed Dividend on Exchange of Convertible Preferred Stock for Common stock

During the three and nine months ended September 30, 2021, the Company recorded a deemed dividend of $0 and $1,192,000 in connection with the exchange of all 250,000 shares of preferred stock for 250,000 shares of common stock and warrants to purchase up to 187,500 shares of common stock, which warrants were subsequently fully exercised on a cashless basis for 79,244 shares of common stock. No such deemed dividend occurred during the three and nine months ended September 30, 2022.

Warrant Inducement Expense

No warrant inducement occurred during the three and nine months ended September 30, 2022.

Liquidity and Capital Resources

Cash and cash equivalents as of September 30, 2022 were $2,644,000, compared to $13,108,000 as of December 31, 2021.

We incurred a net loss of $12,661,000 for the nine months ended September 30, 2022 and used net cash in operating activities of $12,896,000. We incurred a net loss of $ 8,751,000 for the nine months ended September 30, 2021 and used net cash in operating activities of $8,574,000. Excluding non-cash adjustments, the primary reasons for the increase in the use of net cash from operating activities during the nine months ended September 30, 2022, was related to the increase in net loss and increase in inventories, partially offset by an increase in accounts payable.

We have financed our operations to date primarily through the issuance of equity securities, proceeds from the exercise of warrants to purchase common stock and sale of debt instruments. In July 2021, we raised approximately $9,026,000 in net proceeds in a registered direct offering from the issuance and sale of 2,500,000 shares of common stock at a price of $4.00 per share. For the year ended December 31, 2021, we raised net proceeds of approximately $8,303,000 from exercises of warrants which were acquired by investors in conjunction with such financings completed during fiscal 2020. In August 2022, we received net proceeds of $2,483,000, from the issuance of a convertible promissory note to an investor. In September 2022, we entered into a sales agreement with Maxim pursuant to which the Company may sell from time to time, shares of its common stock having an aggregate offering price of up to $4.0 million

32

through the Agent. As of September 30, 2022, the Company has not sold any shares of common stock under the sales agreement. We will need to raise proceeds via the issuance of equity securities and/or the sale of debt instruments in the fourth quarter of 2022 to fund operations through December 31, 2022 and into fiscal year 2023.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that material information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures. Based on the foregoing evaluation, our management concluded that, as of September 30, 2022, our disclosure controls and procedures was effective to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), does not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Controls

There were no changes in the Company’s internal control over financial reporting that occurred during the three months ended September 30, 2022 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

33

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time we may be involved in various claims and legal actions arising in the ordinary course of our business. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.

Item 1A. Risk Factors

Our business, financial condition and operating results are subject to a number of risk factors, both those that are known to us and identified below and others that may arise from time to time. These risks and uncertainties are not the only ones we face and additional risks and uncertainties not presently known to us or that we currently consider immaterial may also impair our business operations. These risk factors could cause our actual results to differ materially from those suggested by forward-looking statements in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (this “Report”) and elsewhere, and may adversely affect our business, financial condition or operating results. If any of these risk factors should occur, moreover, the trading price of our common stock could decline, and investors in our common stock could lose all or part of their investment. These risk factors, along with other information contained in this Report, should be carefully considered in evaluating our prospects.

We depend upon the timely delivery of products from our vendors and purchases from our partners and customers.

We depend on manufacturers and component customers to deliver and purchase hardware and consumer electronics in quantities sufficient to meet customer demand. In addition, we depend on these manufacturers and customers to introduce new and innovative products and components to drive industry sales. During the third quarter of 2022, we have experienced sales declines indirectly through disruption in the supply chain for several of our industry partners or customers whose own supply chains have been disrupted based on a variety of macroeconomic events that may or may not be related to the COVID-19 pandemic, which have resulted in delays throughout the consumer electronics industry. Any material delay in the introduction or delivery, or limited allocations of products or offerings could result in reduced sales by us, which could have a material adverse impact on our financial results. Any reduction in allocation of components or new hardware platforms or other technological advances by vendors or our customers (in which our technology is part of their hardware offering) to third parties such as big box retailers, could also have a material adverse impact on our financial results.

Disruptions and delays in our supply chains as a result of the COVID-19 pandemic could adversely impact manufacturers’ and other customers’ ability to meet customer demand. Additionally, the prioritization of shipments of certain products as a result of the COVID-19 pandemic could cause delays in the shipment or delivery of our products. Such disruptions could also result in reduced sales by us, which could materially and adversely impact on our financial results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

34

Item 6. Exhibits

Exhibit Number	Description
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	Interactive Data Files (embedded within the Inline XBRL document)
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WISA Technologies, Inc.
Date: November 16, 2022	By:	/s/ Brett Moyer
		Brett Moyer
		Chief Executive Officer
		(Duly Authorized Officer and Principal Executive Officer)
Date: November 16, 2022	By:	/s/ George Oliva
		George Oliva
		Principal Financial Officer
		(Duly Authorized Officer and Principal Financial Officer)

36

EX-31.1

Exhibit 31.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Brett Moyer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of WiSA Technologies, Inc. (the “registrant”):

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 16, 2022	/s/ Brett Moyer
	Name:	Brett Moyer
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, George Oliva, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of WiSA Technologies, Inc. (the “registrant”):

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 16, 2022	/s/ George Oliva
	Name:	George Oliva
	Title:	Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of WiSA Technologies, Inc. (the “Company”) for the period ended September 30, 2022 (the “Report”), I, Brett Moyer, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 16, 2022	/s/ Brett Moyer
	Name:	Brett Moyer
	Title:	Chief Executive Officer
		(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of WiSA Technologies, Inc. (the “Company”) for the period ended September 30, 2022 (the “Report”), I, George Oliva, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 16, 2022	/s/ George Oliva
	Name:	George Oliva
	Title:	Chief Financial Officer
		(Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 16, 2022
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Entity File Number	001-38608
Entity Registrant Name	WISA Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	30-1135279
Entity Address, Address Line One	15268 NW Greenbrier Pkwy
Entity Address, City or Town	Beaverton
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97006
City Area Code	408
Local Phone Number	627-4716
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	WISA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,119,353
Entity Central Index Key	0001682149
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021	[1]
Current Assets:
Cash and cash equivalents	$ 2,644,000	$ 13,108,000
Accounts receivable	237,000	214,000
Inventories	7,284,000	4,780,000
Prepaid expenses and other current assets	1,033,000	1,086,000
Total current assets	11,198,000	19,188,000
Property and equipment, net	198,000	162,000
Other assets	174,000	41,000
Total assets	11,570,000	19,391,000
Current Liabilities:
Accounts payable	2,623,000	1,549,000
Accrued liabilities	1,239,000	1,416,000
Total current liabilities	3,862,000	2,965,000
Convertible notes payable, net	1,277,000
Derivative liability	286,000
Warrant liability	719,000	8,000
Other liabilities	74,000	41,000
Total liabilities	6,218,000	3,014,000
Commitments and contingencies (Note 8)
Series A 8% Senior Convertible Preferred stock, par value $0.0001; 0 shares authorized and outstanding as of September 30, 2022; 1,250,000 shares authorized; 0 shares outstanding as of December 31, 2021(liquidation preference of $0)
Stockholders' Equity:
Common stock, par value $0.0001; 200,000,000 shares authorized; 17,119,353 and 15,819,059 shares outstanding as of September 30, 2022 and December 31, 2021, respectively	2,000	2,000
Additional paid-in capital	230,181,000	228,578,000
Accumulated deficit	(224,831,000)	(212,203,000)
Total stockholders' equity	5,352,000	16,377,000
Total liabilities, convertible preferred stock and stockholders' equity	$ 11,570,000	$ 19,391,000

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED BALANCE SHEETS
Temporary equity, dividend rate, percentage	8.00%	8.00%
Temporary equity, par or stated value per share	$ 0.0001	$ 0.0001
Temporary equity, shares authorized	0	1,250,000
Temporary equity, shares outstanding	0	0
Temporary equity, liquidation preference		$ 0
Common stock, par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares outstanding	17,119,353	15,819,059

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue, net	$ 937,000	$ 1,807,000	$ 2,449,000	$ 4,541,000
Cost of revenue	807,000	1,301,000	2,069,000	3,281,000
Gross profit	130,000	506,000	380,000	1,260,000
Operating Expenses:
Research and development	1,939,000	1,322,000	5,359,000	3,800,000
Sales and marketing	1,539,000	1,021,000	4,165,000	2,870,000
General and administrative	1,400,000	1,081,000	3,608,000	3,037,000
Total operating expenses	4,878,000	3,424,000	13,132,000	9,707,000
Loss from operations	(4,748,000)	(2,918,000)	(12,752,000)	(8,447,000)
Interest expense	(173,000)	(3,000)	(174,000)	(9,000)
Change in fair value of warrant liability	274,000	0	274,000	0
Gain on forgiveness of Paycheck Protection Program loan	0	859,000	0	859,000
Other (expense) income	(2,000)	1,000	(7,000)	(6,000)
Warrant inducement expense	0	0	0	(1,146,000)
Loss before provision for income taxes	(4,649,000)	(2,061,000)	(12,659,000)	(8,749,000)
Provision for income taxes	0	0	2,000	2,000
Net loss	(4,649,000)	(2,061,000)	(12,661,000)	(8,751,000)
Convertible preferred stock dividend	0	0	0	(34,000)
Deemed dividend on exchange of convertible preferred stock for common stock	0	0	0	(1,192,000)
Net loss attributable to common stockholders	$ (4,649,000)	$ (2,061,000)	$ (12,661,000)	$ (9,977,000)
Net loss per common share - Basic	$ (0.31)	$ (0.15)	$ (0.85)	$ (0.86)
Net loss per common share - Diluted	$ (0.31)	$ (0.15)	$ (0.85)	$ (0.86)
Weighted average number of common shares used in computing net loss per common share - Basic	15,070,489	13,917,295	14,975,121	11,600,875
Weighted average number of common shares used in computing net loss per common share - Diluted	15,070,489	13,917,295	14,975,121	11,600,875

XML

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Common Shares [Member]	Additional Paid-in Capital	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Deficit	Preferred Stock Convertible Preferred Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Total
Balance at Dec. 31, 2020	$ 1	$ 207,698		$ (200,383)	$ 597		$ 7,316
Balance (in shares) at Dec. 31, 2020	8,402,250				250,000
Issuance of common stock upon warrant exercise		5,095					5,095
Issuance of common stock upon warrant exercise (in shares)	2,086,251
Warrants issued in connection with warrant exercise		567					567
Convertible preferred stock dividend		(20)			$ 20		(20)
Stock-based compensation		254					254
Stock-based compensation (in shares)	643,700
Release of vested restricted common stock (in shares)	352
Net loss				(3,292)			(3,292)
Balance at Mar. 31, 2021	$ 1	213,594		(203,675)	$ 617		9,920
Balance (in shares) at Mar. 31, 2021	11,132,553				250,000
Balance at Dec. 31, 2020	$ 1	207,698		(200,383)	$ 597		7,316
Balance (in shares) at Dec. 31, 2020	8,402,250				250,000
Deemed dividend on exchange of convertible preferred stock for common stock							(1,192)
Net loss							(8,751)
Balance at Sep. 30, 2021	$ 2	228,128		(209,134)			18,996
Balance (in shares) at Sep. 30, 2021	15,803,940
Balance at Dec. 31, 2020	$ 1	207,698		(200,383)	$ 597		7,316
Balance (in shares) at Dec. 31, 2020	8,402,250				250,000
Balance at Dec. 31, 2021	$ 2	228,578		(212,203)			16,377	[1]
Balance (in shares) at Dec. 31, 2021	15,819,059
Balance at Mar. 31, 2021	$ 1	213,594		(203,675)	$ 617		9,920
Balance (in shares) at Mar. 31, 2021	11,132,553				250,000
Issuance of common stock upon warrant exercise		3,159					3,159
Issuance of common stock upon warrant exercise (in shares)	1,360,244
Warrants issued in connection with warrant exercise		579					579
Convertible preferred stock dividend		(14)			$ 14		(14)
Exchange of convertible preferred stock for common stock		1,640			$ (631)		1,640
Exchange of convertible preferred stock for common stock (in shares)	250,000				(250,000)
Warrants issued upon exchange of preferred stock for common stock		570					570
Deemed dividend on exchange of convertible preferred stock for common stock		(1,192)					(1,192)
Stock-based compensation		335					335
Stock-based compensation (in shares)	10,000
Issuance of common stock to vendor		34					34
Issuance of common stock to vendor (in shares)	10,000
Net loss				(3,398)			(3,398)
Balance at Jun. 30, 2021	$ 1	218,705		(207,073)			11,633
Balance (in shares) at Jun. 30, 2021	12,762,797
Issuance of common stock upon warrant exercise		49					49
Issuance of common stock upon warrant exercise (in shares)	19,000
Deemed dividend on exchange of convertible preferred stock for common stock							0
Stock-based compensation		349					349
Stock-based compensation (in shares)	320,800
Release of vested restricted common stock (in shares)	201,343
Registered direct offering, net of issuance costs	$ 1	9,025					9,026
Registered direct offering, net of issuance costs (ins shares)	2,500,000
Net loss				(2,061)			(2,061)
Balance at Sep. 30, 2021	$ 2	228,128		(209,134)			18,996
Balance (in shares) at Sep. 30, 2021	15,803,940
Balance at Dec. 31, 2021	$ 2	228,578		(212,203)			16,377	[1]
Balance (in shares) at Dec. 31, 2021	15,819,059
Stock-based compensation		480					480
Stock-based compensation (in shares)	1,067,400
Release of vested restricted common stock (in shares)	5,668				0
Restricted stock awards cancelled (in shares)	(8,663)
Net loss				(3,904)			(3,904)
Balance at Mar. 31, 2022	$ 2	229,058	$ 33	(216,074)		$ 33	12,986
Balance (in shares) at Mar. 31, 2022	16,883,464
Balance at Dec. 31, 2021	$ 2	228,578		(212,203)			16,377	[1]
Balance (in shares) at Dec. 31, 2021	15,819,059
Deemed dividend on exchange of convertible preferred stock for common stock							0
Net loss							(12,661)
Balance at Sep. 30, 2022	$ 2	230,181		(224,831)			5,352
Balance (in shares) at Sep. 30, 2022	17,119,353
Balance at Mar. 31, 2022	$ 2	229,058	$ 33	(216,074)		$ 33	12,986
Balance (in shares) at Mar. 31, 2022	16,883,464
Stock-based compensation		506					506
Stock-based compensation (in shares)	30,000
Release of vested restricted common stock (in shares)	1,167
Restricted stock awards cancelled (in shares)	(14,809)
Net loss				(4,108)			(4,108)
Balance at Jun. 30, 2022	$ 2	229,564		(220,182)			9,384
Balance (in shares) at Jun. 30, 2022	16,899,822
Deemed dividend on exchange of convertible preferred stock for common stock							0
Stock-based compensation		526					526
Stock-based compensation (in shares)	177,500
Release of vested restricted common stock (in shares)	59,931
Restricted stock awards cancelled (in shares)	(17,900)
Issuance of warrants in connection with convertible promissory note		91					91
Net loss				(4,649)			(4,649)
Balance at Sep. 30, 2022	$ 2	$ 230,181		$ (224,831)			$ 5,352
Balance (in shares) at Sep. 30, 2022	17,119,353

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (4,649,000)	$ (12,661,000)	$ (8,751,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Warrant inducement expense	0	0	1,146,000
Forgiveness of Paycheck Protection Program loan	0	0	(859,000)
Stock-based compensation		1,512,000	938,000
Depreciation and amortization	31,000	91,000	59,000
Expense for issuance of common stock for services		0	34,000
Amortization of debt discounts	156,000	156,000	0
Change in fair value of warrant liability	(274,000)	(274,000)	0
Changes in operating assets and liabilities:
Accounts receivable		(23,000)	(120,000)
Inventories		(2,504,000)	(1,246,000)
Prepaid expenses and other assets		53,000	(572,000)
Other assets		79,000	0
Accounts payable		1,074,000	153,000
Accrued liabilities		(288,000)	644,000
Other liabilities		(111,000)	0
Net cash used in operating activities		(12,896,000)	(8,574,000)
Cash flows from investing activities:
Purchases of property and equipment		(36,000)	(86,000)
Net cash used in investing activities		(36,000)	(86,000)
Cash flows from financing activities:
Proceeds from issuance of common stock upon warrant exercises, net of issuance costs		0	8,303,000
Proceeds from issuance of convertible notes payable, net of issuance costs		2,483,000	0
Repayment of capital lease		(15,000)	(17,000)
Proceeds from issuance of common stock, in registered direct offering, net of issuance costs		0	9,026,000
Net cash provided by financing activities		2,468,000	17,312,000
Net (decrease) increase in cash and cash equivalents		(10,464,000)	8,652,000
Cash and cash equivalents as of beginning of period		13,108,000	7,415,000
Cash and cash equivalents as of end of period	2,644,000	2,644,000	16,067,000
Supplemental disclosure of cash flow information:
Cash paid for interest		17,000	3,000
Cash paid for income taxes		2,000	2,000
Noncash Investing and Financing Activities:
Issuance of warrants in connection with convertible notes payable		1,076,000	0
Derivative liability recorded in connection with issuance of convertible notes payable		286,000
Exchange of convertible preferred stock for common stock		0	1,640,000
Deemed dividend on exchange of convertible preferred stock for common stock	$ 0	0	(1,192,000)
Issuance of warrants in connection with exchange of preferred stock		0	570,000
Convertible preferred stock dividend		$ 0	$ 34,000

XML

Business and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2022

Business and Summary of Significant Accounting Policies

Business and Summary of Significant Accounting Policies

1. Business and Summary of Significant Accounting Policies

WiSA Technologies, Inc formerly known as Summit Wireless Technologies, Inc. (together with its subsidiaries also referred to herein as “we”, “us”, “our”, or the “Company”) was originally formed as a limited liability company in Delaware on July 23, 2010. Our business is to deliver the best-in-class immersive wireless sound technology for intelligent devices and next generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.

NASDAQ Notifications

On June 23, 2022, the Company received a written notification (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), because the closing bid price of the Company’s common stock was below $1.00 per share for the previous thirty (30) consecutive business days. The Notice has no immediate effect on the listing of the common stock, which will continue to trade uninterrupted on the Nasdaq Capital Market under the ticker “WISA.”

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted 180 calendar days from the date of the Notice, or until December 20, 2022 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Requirement. If at any time during the Compliance Period, the bid price of the common stock closes at or above $1.00 per share for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company with written confirmation of compliance with the Minimum Bid Price Requirement and the matter will be closed.

Strategic Advisor

During the third quarter of 2022, the Company retained a strategic advisor to explore strategic opportunities specifically involving the Company’s IP. Potential strategic opportunities that may be explored or evaluated as part of this process include the potential for capital raising transactions, an acquisition, sale of assets, including substantially all of the Company’s assets, merger, business combination, partnership, joint venture, licensing and/or another strategic alternative. Despite the Company’s efforts to identify and evaluate potential strategic transactions, the process may not result in any definitive offer to consummate a strategic transaction, or, if we receive such a definitive offer, the terms may not be as favorable as anticipated or may not result in the execution or approval of a definitive agreement.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to Article 10 of Regulation S-X of the Securities Act of 1933, as amended (“Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include all normal and recurring adjustments that the Company believes are necessary to fairly state the Company’s financial position and the results of operations and cash flows. Interim period results are not necessarily indicative of results of operations or cash flows for a full year or any subsequent interim period. The condensed consolidated balance sheet as of December 31, 2021 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

1. Business and Summary of Significant Accounting Policies, continued

Reclassification

Certain reclassifications have been made to prior periods’ condensed consolidated financial statements to conform to the current period presentation. These reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts at one financial institution. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition as necessary, and sometimes requires partial payment in advance of shipping. As of September 30, 2022 and December 31, 2021, there was no allowance for doubtful accounts. As of September 30, 2022, the Company had two customers accounting for 61%, and 12% of accounts receivable. As of December 31, 2021, the Company had two customers accounting for 35%, and 27% of accounts receivable.

The Company had three customers accounting for 42%, 16% and 12% of its net revenue for the three months ended September 30, 2022. The Company had three customers accounting for 20%, 18%, and 16% of its net revenue for the nine months ended September 30, 2022. The Company had three customers accounting for 63%, 12% and 12% of its net revenue for the three months ended September 30, 2021. The Company had three customers accounting for 33%, 17%, and 10% of its net revenue for the nine months ended September 30, 2021.

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships, dependence on key individuals, and the uncertainties related to supply chain disruptions for customers and suppliers as well as the impact that inflation may have on consumer purchasing and the economy as a whole.

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chip and a single contractor in China for the production of its receive semiconductor chip.

Deferred Offering Costs

Deferred offering costs, consisting of legal, accounting and filing fees relating to public offerings, are capitalized. The deferred offering costs will be offset against public offering proceeds upon the effectiveness of an offering. In the event that an offering is terminated, deferred offering costs will be expensed. As of September 30, 2022 and December 31, 2021, the Company had capitalized $206,000 and $83,000 respectively, of deferred offering costs in prepaid expenses and other current assets on the condensed consolidated balance sheet.

1. Business and Summary of Significant Accounting Policies, continued

Convertible Financial Instruments

The Company bifurcates conversion options and warrants from their host instruments and accounts for them as freestanding derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

When the Company has determined that the embedded conversion options and warrants should be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.

Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or their earliest date of redemption.

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for shares of common stock and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its warrants for shares of common stock and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

In an equity-classified freestanding financial instrument, as of the date that a down round feature is triggered, the Company measures the fair value of the instrument without the down round feature (that is, before the strike price is reduced) and the fair value of the financial instrument with a strike price that reflects the adjustment from the down round. The incremental difference in the fair value is recorded a deemed dividend. As the Company has an accumulated deficit, the deemed dividend is recorded as a reduction of additional paid-in capital in the condensed consolidated balance sheet. The Company increases the net loss available to common stockholders by the amount of the deemed dividend.

Product Warranty

The Company’s products are generally subject to a one-year warranty, which provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within the stated specification. The Company has assessed its historical claims and, to date, product warranty claims have not been significant. The Company will continue to assess if there should be a warranty accrual going forward.

1. Business and Summary of Significant Accounting Policies, continued

Revenue Recognition

The Company generates revenue primarily from two product categories which include the sale of Consumer Audio Products as well as the sale of Components. The Company applies the following five steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company considers customer purchase orders to be the contracts with a customer. Revenues, net of expected discounts, are recognized when the performance obligations of the contract with the customer are satisfied and when control of the promised goods are transferred to the customer, typically when products, which have been determined to be the only distinct performance obligations, are shipped to the customer. Expected costs of assurance warranties and claims are recognized as expense.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components.

Sales to certain distributors are made under arrangements which provide the distributors with price adjustments, price protection, stock rotation and other allowances under certain circumstances. The Company does not provide its customers with a contractual right of return. However, the Company accepts limited returns on a case-by-case basis. These returns, adjustments and other allowances are accounted for as variable consideration. We estimate these amounts based on the expected amount to be provided to customers and reduce revenue recognized. We believe that there will not be significant changes to our estimates of variable consideration.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those amounts are classified as contract liabilities which are included in other current liabilities when the payment is made or it is due, whichever is earlier.

During the three and nine months ended September 30, 2022 and 2021, net revenue consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Components	$	696	$	1,632	$	1,769	$	3,949
Consumer Audio Products		241		175		680		592
Total	$	937	$	1,807	$	2,449	$	4,541

1. Business and Summary of Significant Accounting Policies, continued

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of September 30, 2022 and December 31, 2021.

	September 30,		December 31,
(in thousands)	2022		2021
Contract liabilities	$	32	$	—

Revenue by Geographic Area

In general, revenue disaggregated by geography (See Note 10) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.

Practical Expedients and Exemptions

As part of our adoption of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, we elected to use the following practical expedients: (i) not to adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less; (ii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less; (iii) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

In addition, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Stock-Based Compensation

The Company measures and recognizes the compensation expense for restricted stock units and restricted stock awards granted to employees and directors based on the fair value of the award on the grant date.

Restricted stock units give an employee an interest in Company stock but they have no tangible value until vesting is complete. Restricted stock units and restricted stock awards are equity classified and measured at the fair market value of the underlying stock at the grant date and recognized as expense over the related service or performance period. The Company elected to account for forfeitures as they occur. The fair value of stock awards is based on the quoted price of our common stock on the grant date. Compensation cost for restricted stock units and restricted stock awards is recognized using the straight-line method over the requisite service period.

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and nine months ended September 30, 2022 were $300,000 and $704,000, respectively. Advertising costs for the three and nine months ended September 30, 2021 were $152,000 and $451,000, respectively.

1. Business and Summary of Significant Accounting Policies, continued

Comprehensive Loss

Comprehensive loss represents the changes in equity of an enterprise, other than those resulting from stockholder transactions. Accordingly, comprehensive loss may include certain changes in equity that are excluded from net loss. For the three and nine months ended September 30, 2022 and 2021, the Company’s comprehensive loss is the same as its net loss.

Foreign Currency

The financial position and results of operations of the Company’s foreign operations are measured using currencies other than the U.S. dollar as their functional currencies. Accordingly, for these operations all assets and liabilities are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Expense items are translated using the weighted average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these operations’ financial statements are reported as a separate component of stockholders’ equity, while foreign currency transaction gains or losses, resulting from re-measuring local currency to the U.S. dollar are recorded in the condensed consolidated statement of operations in other income (expense), net and were not material for the three and nine months ended September 30, 2022 and 2021.

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive common share equivalents outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per common share calculation, Series A Preferred Stock, warrants exercisable for common stock, restricted stock units and shares issuable upon the conversion of convertible notes payable are considered to be potentially dilutive securities.

As of September 30, 2022, warrants to purchase 6,702,802 shares of common stock, 1,677,484 shares of restricted stock, 290,625 shares of restricted stock issued under an inducement grant and 731,627 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

As of September 30, 2021, warrants to purchase 4,475,424 shares of common stock, 711,805 shares of restricted stock, 310,000 shares of restricted stock issued under an inducement grant and 456,931 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

Recently Adopted Accounting Pronouncements

Adoption of Accounting Standards Codification (“ASC”) 842

The Company adopted Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2016-02, Leases (“Topic 842”), as of January 1, 2022, using the modified retrospective approach. The modified retrospective approach provides a method for recording existing leases at the beginning of the period of adoption. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to carry forward the historical lease classification and the Company elected the hindsight practical expedient to determine the lease term for existing leases.

1. Business and Summary of Significant Accounting Policies, continued

Adoption of the new standard resulted in the recording of operating lease right-of-use assets of $212,000 and lease liabilities of $327,000, as of January 1, 2022. In addition, the new standard resulted in the recording of an additional $90,000 of property and equipment and the reversal of $58,000 of deferred rent and lease incentive as required under the new standard. The standard did not have an impact on our consolidated results of operations or cash flows. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.

The effect of the changes made to our consolidated January 1, 2022 balance sheet for the adoption of the new lease standard was as follows (in thousands):

	Balance as of		Adjustments		Balance as of
	December 31, 2021		Due to ASC 842		January 1, 2022
Operating lease right-of-use assets	$	—	$	212	$	212
Property and equipment, net		162		90		252
Total assets	$	19,391	$	302	$	19,693
Operating lease liabilities, current	$	—	$	148	$	148
Operating lease liabilities, non-current	$	—	$	179	$	179
Deferred rent and lease incentive	$	58	$	(58)	$	—
Total liabilities	$	3,014	$	269	$	3,283
Accumulated deficit	$	(212,203)	$	33	$	(212,170)
Total stockholders’ equity	$	16,377	$	33	$	16,410
Total liabilities and stockholders’ equity	$	19,391	$	302	$	19,693

Recently Issued and Not Yet Adopted Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06 “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. As an emerging growth company, the Company is allowed to adopt the accounting pronouncement at the same time as non-public business entities. As a result, the Company will adopt the update for its fiscal year beginning after December 15, 2023. The Company is evaluating the impact of this standard on its condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, as amended, which requires the early recognition of credit losses on financing receivables and other financial assets in scope. ASU 2016-13 requires the use of a transition model that will result in the earlier recognition of allowances for losses. The new standard is effective for fiscal years beginning after December 15, 2022. Management is currently evaluating the new standard and its possible impact on the Company’s condensed consolidated financial statements.

We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.

XML

Going Concern

9 Months Ended

Sep. 30, 2022

Going Concern

Going Concern

2. Going Concern

The condensed consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. The Company has incurred net operating losses each year since inception. As of September 30, 2022, the Company had cash and cash equivalents of $2.6 million and reported net cash used in operations of $12.9 million during the nine months ended September 30, 2022. In August of 2022, the Company raised net proceeds of $2.5 million from the issuance of a $3.6 million convertible notes payable. In September 2022, the Company entered into an “at-the-market” sales agreement with Maxim and no proceeds have yet been generated by the sales agreement. The Company expects operating losses to continue in the foreseeable future because of additional costs and expenses related to research and development activities, plans to expand its product portfolio, and costs associated with efforts to increase its market share. The Company’s ability to transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support its cost structure.

Based on current operating levels, the Company will need to raise additional funds by selling additional equity or incurring additional debt. To date, the Company has funded its operations primarily through sales of its common stock in public markets, sales of common and preferred units prior to its initial public offering (“IPO”) proceeds from the exercise of warrants to purchase common stock and the sale of convertible notes and issuance of convertible notes payable. Additionally, future capital requirements will depend on many factors, including the rate of revenue growth, the selling price of the Company’s products, the expansion of sales and marketing activities, the timing and extent of spending on research and development efforts and the continuing market acceptance of the Company’s products. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months from the date of this report.

Management of the Company intends to raise additional funds through the issuance of equity securities or debt. There can be no assurance that, in the event the Company requires additional financing, such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending could have a material adverse effect on the Company’s ability to achieve its intended business objectives. As a result, the substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Balance Sheet Components

9 Months Ended

Sep. 30, 2022

Balance Sheet Components

Balance Sheet Components

3. Balance Sheet Components

Inventories (in thousands):

	September 30,		December 31,
	2022		2021
Raw materials	$	3,116	$	2,676
Work in progress		452		784
Finished goods		3,716		1,320
Total inventories	$	7,284	$	4,780

Property and equipment, net (in thousands):

	September 30,		December 31,
	2022		2021
Machinery and equipment	$	992	$	965
Tooling		11		11
Computer software		—		89
Furniture and fixtures		15		15
Leasehold improvements		127		40
		1,145		1,120
Less: Accumulated depreciation and amortization		(947)		(958)
Property and equipment, net	$	198	$	162

Depreciation and amortization expense for the three months ended September 30, 2022 and 2021 was $31,000 and $20,000, respectively. Depreciation and amortization expense for the nine months ended September 30, 2022 and 2021 was $91,000 and $59,000, respectively.

The cost and accumulated depreciation of assets acquired under finance lease included in machinery and equipment in the above table as of September 30, 2022 were $72,000 and $50,000 respectively.

Accrued liabilities (in thousands):

	September 30,		December 31,
	2022		2021
Accrued rebate	$	417	$	356
Accrued vacation		401		385
Lease liability		142		—
Accrued audit fees		140		191
Customer advances		32		—
Accrued compensation		—		231
Accrued other		107		253
Total accrued liabilities	$	1,239	$	1,416

XML

Borrowings

9 Months Ended

Sep. 30, 2022

Borrowings

Borrowings

4. Borrowings

Convertible Promissory Note

On August 15, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and between the Company and an institutional investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a senior secured convertible note in the principal amount of $3,600,000 (the “Convertible Note”) and a warrant (the “Warrant”) to purchase up to 2,097,022 shares of the Company’s common stock, at an exercise price of $0.997 per share (the “Exercise Price”), in consideration for $3,000,000. Pursuant to the Purchase Agreement, upon the closing of the private placement of the Convertible Note and Warrant, pursuant to which Maxim acted as placement agent (the “Private Placement”), the Company received gross proceeds of $3,000,000. After the deduction of banker fees, commitment fees and other expenses associated with the transaction, the Company received net proceeds of $2,483,000. The Company intends to use the net proceeds primarily for working capital and general corporate purposes.

The Convertible Note matures on August 15, 2024, does not bear interest and ranks senior to the Company’s existing and future indebtedness and is secured to the extent and as provided in the Security Agreements. The Convertible Note is convertible in whole or in part at the option of the Investor into shares of Common stock (the “Conversion Shares”) at the Conversion Price (as defined below) at any time following the date of issuance of the Convertible Note.

The Convertible Note defines “Conversion Price” as equal to the lesser of (a) 90% of the average of the five lowest daily VWAPs (as defined in the Convertible Note) during the previous twenty trading days prior to delivery to the Company of the Investor’s applicable notice of conversion (the “Conversion Notice”) and (b) $0.926 (the “Base Conversion Price”). The Base Conversion Price is subject to full ratchet antidilution protection, subject to a floor conversion price of $0.25 per share (the “Floor Price”), a limitation required by the rules and regulations of Nasdaq, and certain exceptions upon any subsequent transaction at a price lower than the Base Conversion Price then in effect and standard adjustments in the event of stock dividends, stock splits, combinations or similar events; provided that in the event the Conversion Price equals the Floor Price, the Company is required to pay the Investor a cash amount determined pursuant to a formula in the Convertible Note, and provided further that the Floor Price will not apply in the event that the Company obtains Stockholder Approval (as defined in the Purchase Agreement) in accordance with Nasdaq rules. At any time after the closing date of the Private Placement, in the event that the Company issues or sells any shares of common stock or common stock Equivalents (as defined in the Convertible Note), subject to certain exceptions, at an effective price per share lower than the Base Conversion Price then in effect or without consideration, then the Base Conversion Price shall be reduced to the price per share paid for such shares of common stock or common stock Equivalents. Additionally, upon three days’ written notice to the holder after receipt of a Conversion Notice, in lieu of delivering Conversion Shares, the Company has the right to pay the Investor in cash an amount equal to 105% of the portion of the outstanding principal amount stated in such Conversion Notice. Further, at the Investor’s option, the Convertible Note is convertible into shares of common stock or redeemable for 103% of the portion of the outstanding principal amount to be converted in the event that any transaction causes the Conversion Price to be lower than the Floor Price. Subject to certain exceptions, commencing on the Conversion Trigger Date and for a nine-month period after such date, the Investor may convert only up to an aggregate of $250,000 in outstanding principal amount during any calendar month, provided, that if Stockholder Approval has been obtained, the Convertible Note is in default at the time or the Company meets certain capitalization conditions, such conversion limitation would not apply.

The obligations and performance of the Company under the Convertible Note and the Purchase Agreement are secured by: (a) a senior lien granted pursuant to security agreements between the Investor and the Company, on (a) all of the assets of the Company (b) a senior lien granted pursuant to trademark security agreements between the Investor and the Company; (c) a senior lien granted pursuant to a patent security agreement between the Investor and the Company on all of the patent assets of the Company; and (d) a pledge of certain securities pursuant to a pledge agreement between the Investor, the Company (such agreements listed in (a)-(d) above, collectively, the “Security Agreements”). The payment and performance obligations of the Company under the Convertible Note and the Purchase Agreement are guaranteed pursuant to a guaranty by the Company in favor of the Investor.

4. Borrowings, continued

In connection with the August 2022 Note, the Company issued warrants to the Investor and Maxim to purchase common shares of 2,097,022 and 194,384, respectively (see Note 6 – Fair Value Measurements). The sum of the fair value of the warrants, the original issue discount for interest, issuance costs and the derivative liability for the embedded conversion feature for the August 2022 Notes were recorded as debt discounts totaling $2,479,000 to be amortized to interest expense over the respective term using the effective interest method. During the three months ended September 30, 2022, the Company recognized $156,000 of interest expense from the amortization of debt discounts. As of September 30, 2022 the net unamortized debt discounts totaled $2,323,000 and the net carrying value of the convertible notes payable was $1,277,000.

The August 2022 Note contains several embedded conversion features. The Company also concluded that those conversion features require bifurcation from the Convertible Note and subsequent accounting in the same manner as a freestanding derivative. The Company recognized a derivative liability of $286,000 upon execution of the note agreement and that liability is unchanged at September 30, 2022. Accordingly, subsequent changes in the fair value of these conversion features are measured at each reporting period and recognized in the condensed consolidated statement of operations.

Payroll Protection Program Note Agreement

On May 3, 2020, we received a loan (the “PPP Loan”) from Wells Fargo Bank, National Association in the aggregate amount of $847,000, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, which was enacted on March 27, 2020. The PPP Loan was funded on May 7, 2020. The PPP Loan, which is in the form of a PPP promissory note and agreement, dated May 3, 2020 (the “PPP Note Agreement”), had a maturity date of May 3, 2022 and bore interest at a rate of 1.00% per annum. Pursuant to a change in guidance by the U.S. Small Business Administration, the initial monthly payment date of the PPP Note Agreement was deferred from November 1, 2020 to August 18, 2021. The PPP Loan could be prepaid by us at any time prior to maturity with no prepayment penalties.

During the third quarter of 2021, the Company received full loan forgiveness for obligations related to the PPP Loan. The Company accounted for the PPP Loan as debt, and the loan forgiveness was accounted for as a debt extinguishment. The amount of loan and interest forgiven totaling $859,000, was recognized as a gain upon debt extinguishment in the three-month period ended September 30, 2021.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2022

Fair Value Measurements

Fair Value Measurements

5. Fair Value Measurements

The Company measures the fair value of financial instruments using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Each level of input has different levels of subjectivity and difficulty involved in determining fair value.

● Level 1 – Inputs used to measure fair value are unadjusted quoted prices that are available in active markets for the identical assets or liabilities as of the reporting date. Therefore, determining fair value for Level 1 investments generally does not require significant judgment, and the estimation is not difficult.

● Level 2 – Pricing is provided by third-party sources of market information obtained through investment advisors. The Company does not adjust for or apply any additional assumptions or estimates to the pricing information received from its advisors.

● Level 3 – Inputs used to measure fair value are unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions. The determination of fair value for Level 3 instruments involves the most management judgment and subjectivity.

5. Fair Value Measurements, continued

The Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 by level within the fair value hierarchy, are as follows:

(in thousands)	September 30, 2022
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative liability	$	—	$	—	$	286
Warrant liability		—		—		719
	$	—	$	—	$	1,005

(in thousands)	December 31, 2021
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Warrant liability	$	—	$	—	$	8

There were no transfers between Level 1, 2 or 3 during the three and nine months ended September 30, 2022 or September 30, 2021.

Warrant Liability

The changes in the fair value of the warrant liability for the three and nine months ended September 30, 2022 were as follows:

			Fair
			Value at
	December 31,		issuance	Change in	September 30,
	2021		date	fair value	2022
Warrant Liability	$	8	985	(274)	$	719

The calculation of the fair value is described in Note 6 – Convertible Preferred Stock and Stockholders’ Equity.

Derivative Liability

As described above, the conversion provisions embedded in the Convertible Note requires bifurcation and measurement at fair value as a derivative. The fair value was calculated using a Monte Carlo simulation to create a distribution of potential market capitalizations and share prices for the Company on a weekly basis over the assumed period, given the various scenarios. The average value of the Convertible Note was discounted to the valuation date to determine a calibrated discount rate so that the fair value of the Convertible Note was $3 million. The value of the Convertible Note was compared with the value of a hypothetical note with no conversion rights in order to determine the fair value of the conversion feature.

5. Fair Value Measurements, continued

The changes in the fair value of the derivative liability for the three and nine months ended September 30, 2022 were as follows:

			Fair
			Value at
	December 31,		issuance	Change in	September 30,
	2021		date	fair value	2022
Derivative liability	$	—	286	—	$	286

XML

Convertible Preferred Stock and Stockholders' Equity

9 Months Ended

Sep. 30, 2022

Convertible Preferred Stock and Stockholders' Equity

Convertible Preferred Stock and Stockholders' Equity

6. Convertible Preferred Stock and Stockholders’ Equity

Series A 8% Senior Convertible Preferred Stock

On April 18, 2019, we entered into a Securities Purchase Agreement, dated as of April 18, 2019, with a an investor (the “Preferred Investor”) (the “Preferred SPA”), pursuant to which we issued 250,000 shares of our Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which shares did have a stated value of $4.00, grant holders the same voting rights as holders of our shares of common stock, and are convertible into shares of our common stock at price of $80.00 per share, subject to a floor price of $30.00 and to adjustment under our Certificate of Designations of the Preferences, Rights and Limitations of the Series A Preferred Stock, in consideration for $1,000,000 (the “Initial Tranche”). The Series A Preferred Stock may be issued in tranches of at least $500,000 and in an aggregate of up to $5 million. In connection with the Initial Tranche, the Company also issued to the Preferred Investor a warrant to purchase 12,756 shares of our common stock.

The Series A Preferred Stock contained an embedded conversion feature that the Company determined is a derivative requiring bifurcation. The fair value of the derivative liability at the issuance of the Series A Preferred Stock was $216,000, which was recorded as a derivative liability with the offset recorded as a discount to the Series A Preferred Stock.

On June 4, 2021, the Company and the Preferred Investor entered into an exchange agreement pursuant to which the Company exchanged with the Preferred Investor, all outstanding shares of Series A Preferred Stock, for 250,000 shares of common stock and warrants to purchase up to 187,500 shares of common stock. In connection with exchange agreement the Company recorded a deemed dividend of $1,192,000. Immediately following the exchange, the Company no longer had a derivative liability or any preferred stock outstanding.

On August 31, 2022, the Company filed an Elimination of Certificate of Designations of the Preferences, Rights and Limitations of the Series A 8% Senior Convertible Preferred Stock (the “Series A Elimination Certificate”) in order to eliminate and cancel all designations, rights, preferences and limitations of the shares of the Series A 8% Preferred Stock. Prior to the filing of the Series A Elimination Certificate, none of the 1,250,000 authorized shares of Series A Preferred Stock were issued and outstanding, and no shares of Series A Preferred Stock were to be issued subject to the Series A Certificate of Designations. The Series A Elimination Certificate became effective upon its filing with the Secretary of State of the State of Delaware.

As of September 30, 2022, there are no shares of preferred stock issued or outstanding.

Common stock

Carve-Out Plan

For the three months ended March 31, 2021, 352 shares of restricted stock issued under the Carve-Out Plan (the “Plan”), were released with an intrinsic value of approximately $2,000. No shares were subsequently issued under the Plan.

6. Convertible Preferred Stock and Stockholders’ Equity, continued

2018 Long Term Stock Incentive Plan

On January 30, 2018, the Company’s board of directors approved the establishment of the Company’s 2018 Long-Term Stock Incentive Plan (the “LTIP”) and termination of its Carve-Out Plan (the “Plan”). Under the LTIP, the aggregate maximum number of shares of common stock (including shares underlying options) that may be issued under the LTIP pursuant to awards of Restricted Shares or Options will be limited to 15% of the outstanding shares of common stock, which calculation shall be made on the first trading day of each new fiscal year; provided that, in any year no more than 8% of the common stock or derivative securitization with common stock underlying 8% of the common stock may be issued in any fiscal year. Thereafter, the 15% evergreen provision governs the LTIP. For fiscal year 2022, up to 1,265,525 shares of common stock are available for participants under the LTIP.

For the three and nine months ended September 30, 2022, 61,348 and 284,299 shares of restricted stock issued under the LTIP, were released with an intrinsic value of approximately $37,000 and $294,000, respectively. For the three and nine months ended September 30, 2021, 29,064 shares of restricted stock issued under the LTIP, were released with an intrinsic value of approximately $93,000. A summary of activity related to restricted stock awards (excluding the deferred shares) for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
Stock Awards	Shares	Grant Date Fair Value
Non-vested as of January 1, 2022	728,255	$	3.43
Granted	1,274,900	$	1.18
Vested	(284,299)	$	3.07
Forfeited	(41,372)	$	1.92
Non-vested as of September 30, 2022	1,677,484	$	1.82

As of September 30, 2022, the unamortized compensation cost related to the unvested restricted stock awards was approximately $2,374,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 2.2 years.

Inducement Grant

On September 13, 2021, the Company issued 310,000 shares of restricted common stock to Eric Almgren, the Company’s Chief Strategist, as an inducement grant (“September 2021 Inducement Grant”). Such shares were issued outside the Company’s LTIP and 2020 Stock Incentive Plan (the “2020 Stock Plan”). In accordance with the September 2021 Inducement Grant, 77,500 shares will vest monthly over a period of 36 months and the remaining 232,500 will vest in 77,500 increments, upon the achievement of certain company milestones related to the volume weighted average closing price per share of the Company’s common stock, as reported on NASDAQ, for the ten (10) consecutive days in which thresholds of the Company’s market capitalization of $75 million, $100 million and $150 million are achieved. The September 2021 Inducement Grant was valued with an approximate value of $772,000 and will be amortized over 36 months. On August 24, 2022, the September 2021 Inducement Grant’s vesting milestones related to the Company’s market capitalization were revised to $50 million, $75 million and $100 million. This revision was treated as a modification of the original award and the incremental value recorded was not significant. As of September 30, 2022, the unamortized compensation cost related to the unvested September 2021 Inducement Grant was approximately $504,000 which is to be amortized on a straight-line basis over a period of approximately 2.0 years. The Company recorded stock-based compensation of $63,000 and $191,000, respectively, related to this grant for the three and nine months ended September 30, 2022. As of September 30, 2022, 290,625 shares are unvested.

6. Convertible Preferred Stock and Stockholders’ Equity, continued

2020 Stock Incentive Plan

A summary of activity related to restricted stock units under the Company’s 2020 Stock Plan for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
Stock Units	Shares	Grant Date Fair Value
Non-vested as of January 1, 2022	438,462	$	2.36
Granted	—	$	—
Vested	(66,766)	$	2.43
Forfeited	(10,069)	$	2.27
Non-vested as of September 30, 2022	361,627	$	2.35

As of September 30, 2022, the unamortized compensation cost related to the unvested restricted stock units was approximately $451,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 0.9 years.

For the three and nine months ended September 30, 2022, 59,931 and 66,766 shares of restricted stock issued under the 2020 Stock Plan were released with an intrinsic value of approximately $43,000 and $50,000, respectively. For the three and nine months ended September 30, 2021, 201,343 shares of restricted stock units were released under the 2020 Stock Plan with an intrinsic value of approximately $646,000.

2022 Plan

On June 21, 2022, the board of directors adopted the Company’s Technical Team Retention Plan of 2022 (the “2022 Plan”) and the reservation of an aggregate of 500,000 shares of the Company’s common stock authorized for issuance under the 2022 Plan, subject to stockholder approval. The 2022 Plan authorizes the grant of equity-based compensation, to the Company’s key managers, employees, consultants who provide technical and engineering and related services to the Company, in the form of restricted stock and restricted stock units. On August 19, 2022, the Company held the 2022 Annual Meeting of Stockholders and approved the adoption of the 2022 Plan and the reservation of an aggregate of 500,000 shares of the Company’s common stock. On September 19, 2022, the Company granted, an aggregate of 370,000 restricted stock units to managers, employees, consultants. Each restricted stock unit represents the right to receive one share of the Company’s common stock under the 2022 Plan.

A summary of activity related to restricted stock units under the Company’s 2022 Plan for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
		Grant Date
Stock Units	Shares	Fair Value
Non-vested as of January 1, 2022	—	$	—
Granted	370,000	$	0.52
Vested	—	$	—
Forfeited	—	$	—
Non-vested as of September 30, 2022	370,000	$	0.52

As of September 30, 2022, the unamortized compensation cost related to the unvested restricted stock units was approximately $191,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 3.7 years.

6. Convertible Preferred Stock and Stockholders’ Equity, continued

Purchase Agreements

On December 30, 2021, the Company entered into a Sales Agreement with Maxim, pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $4,500,000 from time to time through Maxim. The Company terminated this agreement on September 13, 2022. No shares of common stock were sold under the Sales Agreement.

On September 13, 2022, the Company entered into a 2022 Sales Agreement with Maxim, pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $4,000,000 from time to time through Maxim. No shares of common stock had been sold under the 2022 Sales Agreement as of September 30, 2022.

Warrants for Shares of Common stock

In January 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,221,675 shares of common stock for net proceeds of approximately $2.9 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 305,419 shares of common stock, at an exercise price of $4.20 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $567,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $3.85; expected dividend yield of 0.0%; expected volatility of 60.1%; risk-free interest rate of 0.45% and expected life of 5.0 years.

In June 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,000,000 shares of common stock for net proceeds of approximately $2.3 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 250,000 shares of common stock, at an exercise price of $4.46 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $579,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $4.50; expected dividend yield of 0.0%; expected volatility of 60.7%; risk-free interest rate of 0.77% and expected life of 5.0 years.

In December 2021, the Company granted a warrant to purchase up to 25,000 shares of common stock to Lippert/Heilshorn Associates Inc. The warrant has an exercise price of $1.52 per share and are fully vested. The fair value of the warrant at issuance was $21,000. The fair value of the warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $1.49, expected dividend yield 0%, expected volatility 67%, risk-free interest rate 1.19% and expected life of 5.0 years. The fair value was recorded as professional services with the offset to additional paid-in capital.

In December 2021, the Company granted a warrant to purchase up to 15,000 shares of common stock to Marketing by Design LLC. The warrant has an exercise price of $1.52 per share and are fully vested. The fair value of the warrant at issuance was $12,000. The fair value of the warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $1.49, expected dividend yield 0%, expected volatility 67%, risk-free interest rate 1.19% and expected life of 5.0 years. The fair value was recorded as professional services with the offset to additional paid-in capital.

In connection with the Convertible Note, the Company issued a warrant to the investor to purchase up to 2,097,022 shares of the Company’s common stock, at an exercise price of $0.997 per share (see Note 4 – Borrowings). The grant date fair value of such warrants was $985,000, which was recorded as debt discount with the offset recorded to warrant liability on the condensed consolidated balance sheets. The warrant was recorded as a liability due to the potential variability of its exercise price. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $0.77; expected dividend yield of 0.0%; expected volatility of 80.3%; risk-free interest rate of 2.91% and expected life of 5 years.

6. Convertible Preferred Stock and Stockholders’ Equity, continued

At September 30, 2022, the fair value of the warrant was $719,000. The Company determined the fair value of the warrant using the Black-Scholes Model based on the following weighted average assumptions: common stock price on revaluation date of $0.56; expected dividend yield of 0.0%; expected volatility of 88.3%; risk-free interest rate of 4.06% and expected life of 4.87 years. The corresponding change in the fair value of the warrant liability of $274,000 was recorded to other income on the condensed consolidated statements of operations.

The Warrant is exercisable immediately and will expire on the fifth (5th) anniversary of its date of issuance and may be exercised on a cashless basis in the event of a fundamental transaction involving the Company or if the resale of the shares of common stock underlying the Warrant is not covered by a registration statement. The Exercise Price is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the Exercise Price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

In connection with the Convertible Note, the Company issued a warrant to Maxim to purchase up to 194,384 shares of the Company’s common stock, at an exercise price of $0.997 per share (see Note 4 – Borrowings). The grant date fair value of such warrants was $91,000, which was recorded as debt discount with the offset recorded to additional paid-in capital on the condensed consolidated balance sheets. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $0.77; expected dividend yield of 0.0%; expected volatility of 80.3%; risk-free interest rate of 2.91% and expected life of 5 years.

The Warrant is exercisable at any time on or after the six-month anniversary of the closing date of the Private Placement and will expire on the fifth (5th) anniversary of its date of issuance and may be exercised on a cashless basis in the event that the shares of common stock underlying the warrant are not covered by a registration statement. In addition, the warrant includes a registration rights provision granting Maxim the same registration rights granted to the Convertible Note investor pursuant to the Purchase Agreement. The exercise price is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

Information regarding warrants for common stock outstanding and exercisable as of September 30, 2022 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	September 30, 2022	Life (years)	September 30, 2022
$1.00 - $2.61	3,938,571	2.92	3,734,187
$3.00 - $4.46	2,446,219	2.88	2,446,219
$6.40 - $9.80	32,889	2.41	32,889
$15.80 - $17.50	92,940	0.50	92,940
$24.80 - $125.00	192,183	0.51	192,183
4.39*	6,702,802	3.47	6,498,418

* Weighted average

Warrants exercisable as of September 30, 2022 exclude warrants to purchase 10,000 shares of common stock issued to a marketing firm, which vest upon the achievement of certain milestones and 204,384 shares of common stock issued to Maxim which will become exercisable on February 15, 2023. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are pre-funded warrants under which the holder must only pay $0.20 per share to complete the exercise.

6. Convertible Preferred Stock and Stockholders’ Equity, continued

Information regarding warrants for common stock outstanding and exercisable as of December 31, 2021 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	December 31, 2021	Life (years)	December 31, 2021
$1.52 - $3.90	3,537,965	3.56	3,527,965
$4.20 - $9.80	588,308	4.01	588,308
$15.80 - $17.50	92,963	1.06	92,963
$24.80 - $99.00	222,807	1.13	222,807
$108.00 - $125.00	47,678	0.90	47,678
$7.26*	4,489,721	3.44	4,479,721

* Weighted Average

Warrants exercisable as of December 31, 2021 exclude a warrant to purchase 10,000 shares of common stock issued to a marketing consulting firm. Such warrant will vest in two tranches upon the achievement of certain milestones. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are Pre-Funded Warrants under which the holder must only pay $0.20 per share to complete the exercise.

XML

Income Taxes

9 Months Ended

Sep. 30, 2022

Income Taxes

Income Taxes

7. Income Taxes

The Company recorded a provision for income taxes of $0 and $2,000 for the three and nine months ended September 30, 2022 and $0 and $2,000 for the three and nine months ended September 30, 2021, respectively.

The Company’s effective tax rate was 0% and (0.02%) for the nine months ended September 30, 2022 and 2021, respectively. The difference between the effective tax rate and the federal statutory tax primarily relates to the valuation allowance on the Company’s deferred tax assets.

For interim periods, the Company estimates its annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company also computes the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim periods in which they occur. The Company also recognizes the effect of changes in enacted tax laws or rates in the interim periods in which the changes occur.

As of September 30, 2022 and December 31, 2021, the Company retains a full valuation allowance on its deferred tax assets. The realization of the Company’s deferred tax assets depends primarily on its ability to generate taxable income in future periods. The amount of deferred tax assets considered realizable in future periods may change as management continues to reassess the underlying factors it uses in estimating future taxable income.

The provision for income taxes for the nine months ended September 30, 2022 and 2021 was calculated on a jurisdiction basis.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies

Commitments and Contingencies

8. Commitments and Contingencies

Operating Leases

The Company leases office space under a non-cancellable operating lease that expires in January 2024 and has an option to renew this lease, with renewal rates to be negotiated. Operating lease rentals are expensed on a straight-line basis over the life of the lease beginning on the date we take possession of the property. At lease inception, we determine the lease term by assuming the exercise of those renewal options that are reasonably assured. The exercise of lease renewal options is at our sole discretion. The lease term is used to determine whether a lease is financing or operating and is used to calculate straight-line rent expense. Additionally, the depreciable life of leasehold improvements is limited by the expected lease term. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.

The following table reflects our lease assets and our lease liabilities at September 30, 2022 (in thousands):

	September 30,		January 1,
	2022		2022
Assets:
Operating lease right-of-use assets	$	143	$	212
Liabilities:
Operating lease liabilities, current	$	142	$	148
Operating lease liabilities, non-current	$	74	$	179

Lease Costs:

The components of lease costs were as follows (in thousands):

	Three Months Ended		Nine Months Ended
	September 30, 2022		September 30, 2022
Operating lease cost	$	28	$	74
Short-term lease cost		9		38
Total lease cost	$	37	$	112

As of September 30, 2022, the maturity of operating lease liabilities was as follows (in thousands):

2022 (remaining 3 months)	$	28
2023		173
2024		29
Total lease payments		230
Less: Interest		(14)
Present value of lease liabilities	$	216

Lease Term and Discount Rate:

	September 30, 2022
Weighted-average remaining lease term (in years)	1.4
Weighted-average discount rate	8.0	%

8. Commitments and Contingencies, continued

Other Information:

Supplemental cash flow information related to leases was as follows (in thousands):

	Three Months Ended		Nine Months Ended
	September 30, 2022		September 30, 2022
Operating cash outflows from operating leases	$	42	$	125

Finance Lease

During August 2020, the Company entered into a lease agreement for equipment under a capital lease with a term of 36 months. The equipment under the lease is collateral for the agreement and is included within property and equipment, net on the condensed consolidated balance sheets.

Future minimum lease commitments for the finance lease as of September 30, 2022 are as follows (in thousands):

Payments due in:
Year ending December 31, 2022 (remaining 3 months)	$	7
Year ending December 31, 2023		15
Total minimum lease payments		22
Less: Amounts representing interest		(1)
Present value of finance lease obligations		21
Less: Current portion of finance lease liabilities		21
Other liabilities	$	—

Obligations under the finance lease are included in accrued liabilities and other liabilities on the condensed consolidated balance sheets.

Management Team Retention Bonus

On September 1, 2022, the “Company adopted its Management Team Retention Bonus Plan (the “Retention Plan”), to incentivize certain management level employees (the “Managers”) to remain intact through and shortly following a potential “Change of Control” (as defined in the Retention Plan). The aggregate Retention Plan bonus amounts for all Managers is $1,250,000.

The Retention Plan provides that each Manager is eligible to receive a lump sum cash amount under the Retention Plan, on the earlier of the six-month anniversary of the date of a Change of Control or at the time of such Manager’s involuntary termination other than for “Cause” (as defined in the Retention Plan) or termination for “Good Reason” (as defined in the Retention Plan). The Retention Plan will terminate upon the earlier of June 30, 2023 if a Change of Control has not occurred by such date or upon the payment of all Retention Bonus Amounts. As of September 30, 2022, no accrual has been made under the Retention Plan.

8. Commitments and Contingencies, continued

Contingencies

In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of a possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred.

The Company’s management does not believe that any such matters, individually or in the aggregate, will have a materially adverse effect on the Company’s condensed consolidated financial statements.

XML

Related Parties

9 Months Ended

Sep. 30, 2022

Related Parties

Related Parties

9. Related Parties

Helge Kristensen

Mr. Kristensen has served as a member of the Company’s board of directors since 2010. Mr. Kristensen serves as vice president of Hansong Technology, an original device manufacturer of audio products based in China, president of Platin Gate Technology (Nanjing) Co. Ltd, a company with focus on service-branding in lifestyle products as well as pro line products based in China and co-founder and director of Inizio Capital, an investment company based in the Cayman Islands.

For the three months ended September 30, 2022 and 2021, Hansong Technology purchased modules from the Company of approximately $146,000 and $263,000, respectively, and made payments to the Company of approximately $191,000 and $333,000, respectively. For the three months ended September 30, 2022 and 2021, Hansong Technology sold speaker products to the Company of approximately $908,000 and $96,000, respectively, and the Company made payments to Hansong Technology of approximately $516,000 and $309,000, respectively.

For the nine months ended September 30, 2022 and 2021, Hansong Technology purchased modules from the Company of approximately $337,000 and $496,000, respectively, and made payments to the Company of approximately $191,000 and $380,000, respectively. For the nine months ended September 30, 2022 and 2021, Hansong Technology sold speaker products to the Company of approximately $1,367,000 and $854,000, respectively, and the Company made payments to Hansong Technology of approximately $1,306,000 and $962,000, respectively.

At September 30, 2022 and 2021, the Company owed Hansong Technology approximately $851,000 and $96,000, respectively. At September 30, 2022 and 2021, Hansong Technology owed the Company approximately $146,000 and $129,000, respectively.
​

As of September 30, 2022 and December 31, 2021, Mr. Kristensen owned less than 1.0% of the outstanding shares of the Company’s common stock.

David Howitt

Mr. Howitt has served as a member of the Company’s board of directors since December 2021. Mr. Howitt is founder and CEO of Meriwether Group LLC, (“Meriwether”), a strategic consulting firm that works with disruptive consumer brands. Meriwether is the manager of Meriwether Accelerators LLC (“Meriwether Accelerators”).

9.Related Parties, continued

The Company is a party to a professional services agreement with Meriwether Accelerators, dated as of January 15, 2022, pursuant to which, the Company has agreed to pay Meriwether Accelerators (i) $7,500 per month for a period of six months; and (ii) issue 10,000 shares of common stock for each partnership brought to fruition as a result of Meriwether Accelerators’ services and introduction, for up to 40,000 shares of common stock, which shares will have piggyback registration rights, in consideration for certain licensing services and strategic partnership collaborations to be provided by Meriwether Accelerators as set forth in such agreement. For the three and nine months ended September 30, 2022, the Company paid Meriwether Accelerators $8,000 and $45,000, respectively. As of September 30, 2022, the Company has not issued any shares of common stock to Meriwether Accelerators under this agreement nor has it recorded any compensation expense related to the issuance of common stock.

As of September 30, 2022 and December 31, 2021, Mr. Howitt owned less than 1.0% of the outstanding shares of the Company’s common stock.

XML

Segment Information

9 Months Ended

Sep. 30, 2022

Segment Information

Segment Information

10. Segment Information

The Company operates in one business segment. Our chief decision-maker, the President and Chief Executive Officer, evaluates our performance based on company-wide consolidated results.

Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue by geographic region for the three and nine months ended September 30, 2022 and 2021 was as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
(in thousands)	2022		2021		2022		2021
North America	$	244	$	166	$	681	$	710
Europe		62		162		411		403
Asia Pacific		631		1,479		1,357		3,428
Total	$	937	$	1,807	$	2,449	$	4,541

Substantially all of our long-lived assets are located in the United States.

XML

Business and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2022

Business and Summary of Significant Accounting Policies

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to Article 10 of Regulation S-X of the Securities Act of 1933, as amended (“Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include all normal and recurring adjustments that the Company believes are necessary to fairly state the Company’s financial position and the results of operations and cash flows. Interim period results are not necessarily indicative of results of operations or cash flows for a full year or any subsequent interim period. The condensed consolidated balance sheet as of December 31, 2021 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Concentration of Credit Risk and Other Risks and Uncertainties

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts at one financial institution. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition as necessary, and sometimes requires partial payment in advance of shipping. As of September 30, 2022 and December 31, 2021, there was no allowance for doubtful accounts. As of September 30, 2022, the Company had two customers accounting for 61%, and 12% of accounts receivable. As of December 31, 2021, the Company had two customers accounting for 35%, and 27% of accounts receivable.

The Company had three customers accounting for 42%, 16% and 12% of its net revenue for the three months ended September 30, 2022. The Company had three customers accounting for 20%, 18%, and 16% of its net revenue for the nine months ended September 30, 2022. The Company had three customers accounting for 63%, 12% and 12% of its net revenue for the three months ended September 30, 2021. The Company had three customers accounting for 33%, 17%, and 10% of its net revenue for the nine months ended September 30, 2021.

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships, dependence on key individuals, and the uncertainties related to supply chain disruptions for customers and suppliers as well as the impact that inflation may have on consumer purchasing and the economy as a whole.

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chip and a single contractor in China for the production of its receive semiconductor chip.

Deferred Offering Costs

Deferred Offering Costs

Deferred offering costs, consisting of legal, accounting and filing fees relating to public offerings, are capitalized. The deferred offering costs will be offset against public offering proceeds upon the effectiveness of an offering. In the event that an offering is terminated, deferred offering costs will be expensed. As of September 30, 2022 and December 31, 2021, the Company had capitalized $206,000 and $83,000 respectively, of deferred offering costs in prepaid expenses and other current assets on the condensed consolidated balance sheet.

Convertible Financial Instruments

Convertible Financial Instruments

The Company bifurcates conversion options and warrants from their host instruments and accounts for them as freestanding derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

When the Company has determined that the embedded conversion options and warrants should be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.

Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or their earliest date of redemption.

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for shares of common stock and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its warrants for shares of common stock and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

In an equity-classified freestanding financial instrument, as of the date that a down round feature is triggered, the Company measures the fair value of the instrument without the down round feature (that is, before the strike price is reduced) and the fair value of the financial instrument with a strike price that reflects the adjustment from the down round. The incremental difference in the fair value is recorded a deemed dividend. As the Company has an accumulated deficit, the deemed dividend is recorded as a reduction of additional paid-in capital in the condensed consolidated balance sheet. The Company increases the net loss available to common stockholders by the amount of the deemed dividend.

Product Warranty

Product Warranty

The Company’s products are generally subject to a one-year warranty, which provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within the stated specification. The Company has assessed its historical claims and, to date, product warranty claims have not been significant. The Company will continue to assess if there should be a warranty accrual going forward.

Revenue Recognition

1. Business and Summary of Significant Accounting Policies, continued

Revenue Recognition

The Company generates revenue primarily from two product categories which include the sale of Consumer Audio Products as well as the sale of Components. The Company applies the following five steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company considers customer purchase orders to be the contracts with a customer. Revenues, net of expected discounts, are recognized when the performance obligations of the contract with the customer are satisfied and when control of the promised goods are transferred to the customer, typically when products, which have been determined to be the only distinct performance obligations, are shipped to the customer. Expected costs of assurance warranties and claims are recognized as expense.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components.

Sales to certain distributors are made under arrangements which provide the distributors with price adjustments, price protection, stock rotation and other allowances under certain circumstances. The Company does not provide its customers with a contractual right of return. However, the Company accepts limited returns on a case-by-case basis. These returns, adjustments and other allowances are accounted for as variable consideration. We estimate these amounts based on the expected amount to be provided to customers and reduce revenue recognized. We believe that there will not be significant changes to our estimates of variable consideration.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those amounts are classified as contract liabilities which are included in other current liabilities when the payment is made or it is due, whichever is earlier.

During the three and nine months ended September 30, 2022 and 2021, net revenue consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Components	$	696	$	1,632	$	1,769	$	3,949
Consumer Audio Products		241		175		680		592
Total	$	937	$	1,807	$	2,449	$	4,541

Contract Balances

1. Business and Summary of Significant Accounting Policies, continued

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of September 30, 2022 and December 31, 2021.

	September 30,		December 31,
(in thousands)	2022		2021
Contract liabilities	$	32	$	—

Revenue by Geographic Area

Revenue by Geographic Area

In general, revenue disaggregated by geography (See Note 10) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.

Practical Expedients and Exemptions

Practical Expedients and Exemptions

As part of our adoption of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, we elected to use the following practical expedients: (i) not to adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less; (ii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less; (iii) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

In addition, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Stock-Based Compensation

Stock-Based Compensation

The Company measures and recognizes the compensation expense for restricted stock units and restricted stock awards granted to employees and directors based on the fair value of the award on the grant date.

Restricted stock units give an employee an interest in Company stock but they have no tangible value until vesting is complete. Restricted stock units and restricted stock awards are equity classified and measured at the fair market value of the underlying stock at the grant date and recognized as expense over the related service or performance period. The Company elected to account for forfeitures as they occur. The fair value of stock awards is based on the quoted price of our common stock on the grant date. Compensation cost for restricted stock units and restricted stock awards is recognized using the straight-line method over the requisite service period.

Advertising Costs

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and nine months ended September 30, 2022 were $300,000 and $704,000, respectively. Advertising costs for the three and nine months ended September 30, 2021 were $152,000 and $451,000, respectively.

Comprehensive Loss

1. Business and Summary of Significant Accounting Policies, continued

Comprehensive Loss

Comprehensive loss represents the changes in equity of an enterprise, other than those resulting from stockholder transactions. Accordingly, comprehensive loss may include certain changes in equity that are excluded from net loss. For the three and nine months ended September 30, 2022 and 2021, the Company’s comprehensive loss is the same as its net loss.

Foreign Currency

Foreign Currency

The financial position and results of operations of the Company’s foreign operations are measured using currencies other than the U.S. dollar as their functional currencies. Accordingly, for these operations all assets and liabilities are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Expense items are translated using the weighted average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these operations’ financial statements are reported as a separate component of stockholders’ equity, while foreign currency transaction gains or losses, resulting from re-measuring local currency to the U.S. dollar are recorded in the condensed consolidated statement of operations in other income (expense), net and were not material for the three and nine months ended September 30, 2022 and 2021.

Net Loss per Common Share

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive common share equivalents outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per common share calculation, Series A Preferred Stock, warrants exercisable for common stock, restricted stock units and shares issuable upon the conversion of convertible notes payable are considered to be potentially dilutive securities.

As of September 30, 2022, warrants to purchase 6,702,802 shares of common stock, 1,677,484 shares of restricted stock, 290,625 shares of restricted stock issued under an inducement grant and 731,627 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

As of September 30, 2021, warrants to purchase 4,475,424 shares of common stock, 711,805 shares of restricted stock, 310,000 shares of restricted stock issued under an inducement grant and 456,931 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

Recently Adopted Accounting Pronouncements.

Recently Adopted Accounting Pronouncements

Adoption of Accounting Standards Codification (“ASC”) 842

The Company adopted Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2016-02, Leases (“Topic 842”), as of January 1, 2022, using the modified retrospective approach. The modified retrospective approach provides a method for recording existing leases at the beginning of the period of adoption. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to carry forward the historical lease classification and the Company elected the hindsight practical expedient to determine the lease term for existing leases.

1. Business and Summary of Significant Accounting Policies, continued

Adoption of the new standard resulted in the recording of operating lease right-of-use assets of $212,000 and lease liabilities of $327,000, as of January 1, 2022. In addition, the new standard resulted in the recording of an additional $90,000 of property and equipment and the reversal of $58,000 of deferred rent and lease incentive as required under the new standard. The standard did not have an impact on our consolidated results of operations or cash flows. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.

The effect of the changes made to our consolidated January 1, 2022 balance sheet for the adoption of the new lease standard was as follows (in thousands):

	Balance as of		Adjustments		Balance as of
	December 31, 2021		Due to ASC 842		January 1, 2022
Operating lease right-of-use assets	$	—	$	212	$	212
Property and equipment, net		162		90		252
Total assets	$	19,391	$	302	$	19,693
Operating lease liabilities, current	$	—	$	148	$	148
Operating lease liabilities, non-current	$	—	$	179	$	179
Deferred rent and lease incentive	$	58	$	(58)	$	—
Total liabilities	$	3,014	$	269	$	3,283
Accumulated deficit	$	(212,203)	$	33	$	(212,170)
Total stockholders’ equity	$	16,377	$	33	$	16,410
Total liabilities and stockholders’ equity	$	19,391	$	302	$	19,693

Recently Issued and Not Yet Adopted Accounting Pronouncements

Recently Issued and Not Yet Adopted Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06 “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. As an emerging growth company, the Company is allowed to adopt the accounting pronouncement at the same time as non-public business entities. As a result, the Company will adopt the update for its fiscal year beginning after December 15, 2023. The Company is evaluating the impact of this standard on its condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, as amended, which requires the early recognition of credit losses on financing receivables and other financial assets in scope. ASU 2016-13 requires the use of a transition model that will result in the earlier recognition of allowances for losses. The new standard is effective for fiscal years beginning after December 15, 2022. Management is currently evaluating the new standard and its possible impact on the Company’s condensed consolidated financial statements.

We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.

XML

Business and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Business and Summary of Significant Accounting Policies

Schedule of net revenue

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Components	$	696	$	1,632	$	1,769	$	3,949
Consumer Audio Products		241		175		680		592
Total	$	937	$	1,807	$	2,449	$	4,541

Schedule of Contract Balances

	September 30,		December 31,
(in thousands)	2022		2021
Contract liabilities	$	32	$	—

Schedule of Recently Adopted Accounting Pronouncements

The effect of the changes made to our consolidated January 1, 2022 balance sheet for the adoption of the new lease standard was as follows (in thousands):

	Balance as of		Adjustments		Balance as of
	December 31, 2021		Due to ASC 842		January 1, 2022
Operating lease right-of-use assets	$	—	$	212	$	212
Property and equipment, net		162		90		252
Total assets	$	19,391	$	302	$	19,693
Operating lease liabilities, current	$	—	$	148	$	148
Operating lease liabilities, non-current	$	—	$	179	$	179
Deferred rent and lease incentive	$	58	$	(58)	$	—
Total liabilities	$	3,014	$	269	$	3,283
Accumulated deficit	$	(212,203)	$	33	$	(212,170)
Total stockholders’ equity	$	16,377	$	33	$	16,410
Total liabilities and stockholders’ equity	$	19,391	$	302	$	19,693

XML

Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2022

Balance Sheet Components

Schedule of Inventories

Inventories (in thousands):

	September 30,		December 31,
	2022		2021
Raw materials	$	3,116	$	2,676
Work in progress		452		784
Finished goods		3,716		1,320
Total inventories	$	7,284	$	4,780

Schedule of Property and equipment, net

Property and equipment, net (in thousands):

	September 30,		December 31,
	2022		2021
Machinery and equipment	$	992	$	965
Tooling		11		11
Computer software		—		89
Furniture and fixtures		15		15
Leasehold improvements		127		40
		1,145		1,120
Less: Accumulated depreciation and amortization		(947)		(958)
Property and equipment, net	$	198	$	162

Schedule of Accrued liabilities

Accrued liabilities (in thousands):

	September 30,		December 31,
	2022		2021
Accrued rebate	$	417	$	356
Accrued vacation		401		385
Lease liability		142		—
Accrued audit fees		140		191
Customer advances		32		—
Accrued compensation		—		231
Accrued other		107		253
Total accrued liabilities	$	1,239	$	1,416

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Measurements

Schedule of Company's financial assets and liabilities that are measured at fair value on a recurring basis

(in thousands)	September 30, 2022
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative liability	$	—	$	—	$	286
Warrant liability		—		—		719
	$	—	$	—	$	1,005

(in thousands)	December 31, 2021
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Warrant liability	$	—	$	—	$	8

Derivative Liability

Fair Value Measurements

Schedule of changes in the fair value of the warrant liability and derivative liability

			Fair
			Value at
	December 31,		issuance	Change in	September 30,
	2021		date	fair value	2022
Derivative liability	$	—	286	—	$	286

Warrant Liability

Fair Value Measurements

Schedule of changes in the fair value of the warrant liability and derivative liability

			Fair
			Value at
	December 31,		issuance	Change in	September 30,
	2021		date	fair value	2022
Warrant Liability	$	8	985	(274)	$	719

XML

Convertible Preferred Stock and Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2022

Summary of activity related to restricted stock awards/units

		Weighted-Average
Stock Awards	Shares	Grant Date Fair Value
Non-vested as of January 1, 2022	728,255	$	3.43
Granted	1,274,900	$	1.18
Vested	(284,299)	$	3.07
Forfeited	(41,372)	$	1.92
Non-vested as of September 30, 2022	1,677,484	$	1.82

Schedule of Information regarding warrants for common stock outstanding and exercisable

Information regarding warrants for common stock outstanding and exercisable as of September 30, 2022 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	September 30, 2022	Life (years)	September 30, 2022
$1.00 - $2.61	3,938,571	2.92	3,734,187
$3.00 - $4.46	2,446,219	2.88	2,446,219
$6.40 - $9.80	32,889	2.41	32,889
$15.80 - $17.50	92,940	0.50	92,940
$24.80 - $125.00	192,183	0.51	192,183
4.39*	6,702,802	3.47	6,498,418

* Weighted average

Information regarding warrants for common stock outstanding and exercisable as of December 31, 2021 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	December 31, 2021	Life (years)	December 31, 2021
$1.52 - $3.90	3,537,965	3.56	3,527,965
$4.20 - $9.80	588,308	4.01	588,308
$15.80 - $17.50	92,963	1.06	92,963
$24.80 - $99.00	222,807	1.13	222,807
$108.00 - $125.00	47,678	0.90	47,678
$7.26*	4,489,721	3.44	4,479,721

* Weighted Average

2020 Stock Incentive Plan

Summary of activity related to restricted stock awards/units

A summary of activity related to restricted stock units under the Company’s 2020 Stock Plan for the nine months ended September 30, 2022 is presented below:

		Weighted-Average
Stock Units	Shares	Grant Date Fair Value
Non-vested as of January 1, 2022	438,462	$	2.36
Granted	—	$	—
Vested	(66,766)	$	2.43
Forfeited	(10,069)	$	2.27
Non-vested as of September 30, 2022	361,627	$	2.35

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies

Schedule of lease assets and lease liabilities

The following table reflects our lease assets and our lease liabilities at September 30, 2022 (in thousands):

	September 30,		January 1,
	2022		2022
Assets:
Operating lease right-of-use assets	$	143	$	212
Liabilities:
Operating lease liabilities, current	$	142	$	148
Operating lease liabilities, non-current	$	74	$	179

Schedule of lease costs

The components of lease costs were as follows (in thousands):

	Three Months Ended		Nine Months Ended
	September 30, 2022		September 30, 2022
Operating lease cost	$	28	$	74
Short-term lease cost		9		38
Total lease cost	$	37	$	112

Schedule of maturity of operating lease liabilities

As of September 30, 2022, the maturity of operating lease liabilities was as follows (in thousands):

2022 (remaining 3 months)	$	28
2023		173
2024		29
Total lease payments		230
Less: Interest		(14)
Present value of lease liabilities	$	216

Schedule of lease term and discount rate

	September 30, 2022
Weighted-average remaining lease term (in years)	1.4
Weighted-average discount rate	8.0	%

Schedule of supplemental cash flow information related to leases

Supplemental cash flow information related to leases was as follows (in thousands):

	Three Months Ended		Nine Months Ended
	September 30, 2022		September 30, 2022
Operating cash outflows from operating leases	$	42	$	125

Summary of future minimum lease commitments for finance lease

Future minimum lease commitments for the finance lease as of September 30, 2022 are as follows (in thousands):

Payments due in:
Year ending December 31, 2022 (remaining 3 months)	$	7
Year ending December 31, 2023		15
Total minimum lease payments		22
Less: Amounts representing interest		(1)
Present value of finance lease obligations		21
Less: Current portion of finance lease liabilities		21
Other liabilities	$	—

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2022

Segment Information

Schedule of net revenue by geographic region

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
(in thousands)	2022		2021		2022		2021
North America	$	244	$	166	$	681	$	710
Europe		62		162		411		403
Asia Pacific		631		1,479		1,357		3,428
Total	$	937	$	1,807	$	2,449	$	4,541

XML

Business and Summary of Significant Accounting Policies - Schedule of Contract Balances (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Business and Summary of Significant Accounting Policies
Contract liabilities	$ 32

XML

Business and Summary of Significant Accounting Policies (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($) customer	Sep. 30, 2021 USD ($) customer	Sep. 30, 2022 USD ($) customer segment shares	Sep. 30, 2021 USD ($) customer shares	Dec. 31, 2021 USD ($) customer
Business and Summary of Significant Accounting Policies
Allowance for doubtful accounts | $	$ 0		$ 0		$ 0
Deferred offering costs | $	206,000		$ 206,000		$ 83,000
Number of operating segments | segment			1
Advertising costs | $	$ 300,000	$ 152,000	$ 704,000	$ 451,000
Warranty period of company products			1 year
Warrant
Business and Summary of Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share, amount			6,702,802	4,475,424
Restricted stock
Business and Summary of Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share, amount			1,677,484	711,805
Restricted stock units
Business and Summary of Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share, amount			290,625	310,000
Convertible Preferred Stock
Business and Summary of Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share, amount			731,627	456,931
Accounts Receivable | Customer Concentration Risk
Business and Summary of Significant Accounting Policies
Number of customers | customer			2		2
Accounts Receivable | Customer Concentration Risk | Customer 1
Business and Summary of Significant Accounting Policies
Concentration risk, percentage			61.00%		35.00%
Accounts Receivable | Customer Concentration Risk | Customer 2
Business and Summary of Significant Accounting Policies
Concentration risk, percentage			12.00%		27.00%
Sales Revenue, Net | Customer Concentration Risk
Business and Summary of Significant Accounting Policies
Number of customers | customer	3	3	3	3
Sales Revenue, Net | Customer Concentration Risk | Customer 1
Business and Summary of Significant Accounting Policies
Concentration risk, percentage	42.00%	63.00%	20.00%	33.00%
Sales Revenue, Net | Customer Concentration Risk | Customer 2
Business and Summary of Significant Accounting Policies
Concentration risk, percentage	16.00%	12.00%	18.00%	17.00%
Sales Revenue, Net | Customer Concentration Risk | Customer 3
Business and Summary of Significant Accounting Policies
Concentration risk, percentage	12.00%	12.00%	16.00%	10.00%

XML

Business and Summary of Significant Accounting Policies - Schedule of net revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Business and Summary of Significant Accounting Policies
Revenue, net	$ 937	$ 1,807	$ 2,449	$ 4,541
Components
Business and Summary of Significant Accounting Policies
Revenue, net	696	1,632	1,769	3,949
Consumer Audio Products
Business and Summary of Significant Accounting Policies
Revenue, net	$ 241	$ 175	$ 680	$ 592

XML

Business and Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements (Details) - USD ($)	Sep. 30, 2022	Jan. 01, 2022	Dec. 31, 2021
Business and Summary of Significant Accounting Policies
Operating lease, liability	$ 216,000
Property, plant and equipment, net	$ 198,000		$ 162,000	[1]
Accounting Standards Update 2016-02 Leases
Business and Summary of Significant Accounting Policies
Operating lease right-of-use asset		$ 212,000
Operating lease, liability		327,000
Property, plant and equipment, net			162,000
Deferred rent credit			$ 58,000
Accounting Standards Update 2016-02 Leases | Cumulative Effect, Period of Adoption, Adjustment
Business and Summary of Significant Accounting Policies
Operating lease right-of-use asset		212,000
Property, plant and equipment, net		90,000
Deferred rent credit		$ (58,000)

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

Business and Summary of Significant Accounting Policies - Schedule of Recently Adopted Accounting Pronouncement (Details) - USD ($)	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jan. 01, 2022	Dec. 31, 2021		Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Business and Summary of Significant Accounting Policies
Operating lease, liability	$ 216,000
Property, plant and equipment, net	198,000				$ 162,000	[1]
Total assets	11,570,000				19,391,000	[1]
Operating lease liabilities, current	142,000
Total liabilities	6,218,000				3,014,000	[1]
Accumulated deficit	(224,831,000)				(212,203,000)	[1]
Stockholders' equity	5,352,000	$ 9,384,000	$ 12,986,000		16,377,000	[1]	$ 18,996,000	$ 11,633,000	$ 9,920,000	$ 7,316,000
Total liabilities and stockholders' equity	$ 11,570,000				19,391,000	[1]
Cumulative Effect, Period of Adoption, Adjustment
Business and Summary of Significant Accounting Policies
Stockholders' equity			$ 33,000
Accounting Standards Update 2016-02 Leases
Business and Summary of Significant Accounting Policies
Operating lease right-of-use asset				$ 212,000
Operating lease, liability				327,000
Property, plant and equipment, net					162,000
Total assets					19,391,000
Deferred rent credit					58,000
Total liabilities					3,014,000
Accumulated deficit					(212,203,000)
Stockholders' equity					16,377,000
Total liabilities and stockholders' equity					$ 19,391,000
Accounting Standards Update 2016-02 Leases | Cumulative Effect, Period of Adoption, Adjusted Balance
Business and Summary of Significant Accounting Policies
Operating lease right-of-use asset				212,000
Property, plant and equipment, net				252,000
Total assets				19,693,000
Operating lease liabilities, current				148,000
Operating lease liabilities, non-current				179,000
Total liabilities				3,283,000
Accumulated deficit				(212,170,000)
Stockholders' equity				16,410,000
Total liabilities and stockholders' equity				19,693,000
Accounting Standards Update 2016-02 Leases | Cumulative Effect, Period of Adoption, Adjustment
Business and Summary of Significant Accounting Policies
Operating lease right-of-use asset				212,000
Property, plant and equipment, net				90,000
Total assets				302,000
Operating lease liabilities, current				148,000
Operating lease liabilities, non-current				179,000
Deferred rent credit				(58,000)
Total liabilities				269,000
Accumulated deficit				33,000
Stockholders' equity				33,000
Total liabilities and stockholders' equity				$ 302,000

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

Going Concern (Details) - USD ($)	1 Months Ended	9 Months Ended
	Aug. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Aug. 15, 2022	Dec. 31, 2021	[1]
Going Concern
Cash and cash equivalents		$ 2,644,000			$ 13,108,000
Net cash used in operations		(12,896,000)	$ (8,574,000)
Common stock, value, issued		2,000			$ 2,000
Net proceeds from issuance of convertible notes payable		$ 2,483,000	$ 0
Convertible Promissory Note
Going Concern
Net proceeds from issuance of convertible notes payable	$ 2,500,000
Principal amount	$ 3,600,000			$ 3,600,000

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Schedule of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Balance Sheet Components
Raw materials	$ 3,116	$ 2,676
Work in progress	452	784
Finished goods	3,716	1,320
Total inventories	$ 7,284	$ 4,780	[1]

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Schedule of Property and equipment, net (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Balance Sheet Components
Property and equipment, gross	$ 1,145	$ 1,120
Less: Accumulated depreciation and amortization	(947)	(958)
Property and equipment, net	198	162	[1]
Machinery and equipment
Balance Sheet Components
Property and equipment, gross	992	965
Tooling
Balance Sheet Components
Property and equipment, gross	11	11
Computer software
Balance Sheet Components
Property and equipment, gross		89
Furniture and fixtures
Balance Sheet Components
Property and equipment, gross	15	15
Leasehold improvements
Balance Sheet Components
Property and equipment, gross	$ 127	$ 40

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Schedule of Accrued liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Balance Sheet Components
Accrued rebate	$ 417	$ 356
Accrued vacation	401	385
Lease liability	142
Accrued audit fees	140	191
Customer advances	32
Accrued compensation		231
Accrued other	107	253
Total accrued liabilities	$ 1,239	$ 1,416	[1]

[1] The condensed consolidated balance sheet as of December 31, 2021 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Balance Sheet Components
Depreciation and amortization expense	$ 31,000	$ 20,000	$ 91,000	$ 59,000
Property and equipment, gross	1,145,000		1,145,000		$ 1,120,000
Accumulated depreciation	947,000		947,000		$ 958,000
Capital lease
Balance Sheet Components
Property and equipment, gross	72,000		72,000
Accumulated depreciation	$ 50,000		$ 50,000

XML

Borrowings - Convertible Promissory Note (Details)		3 Months Ended	9 Months Ended
	Aug. 15, 2022 USD ($) D item $ / shares shares	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Aug. 31, 2022 USD ($)
Borrowings
Net carrying value of the convertible notes payable		$ 1,277,000	$ 1,277,000
Derivative Liability, Noncurrent		286,000	286,000
Convertible Notes Payable, Noncurrent		1,277,000	1,277,000
Gross proceeds	$ 3,000,000
Net proceeds	$ 2,483,000
Floor price | $ / shares	$ 0.25
Amortization of debt discounts		156,000	156,000	$ 0
Investor
Borrowings
Number of common stock shares called by warrants issued | shares	2,097,022
Exercise price of warrants | $ / shares	$ 0.997
Maxim Group LLC
Borrowings
Number of common stock shares called by warrants issued | shares	194,384
Exercise price of warrants | $ / shares	$ 0.997
Convertible Promissory Note
Borrowings
Principal amount	$ 3,600,000				$ 3,600,000
Debt discounts	$ 2,479,000	$ 2,323,000	$ 2,323,000
Conversion price, percentage of average VWAPs considered	90.00%
Conversion price, Number of lowest daily VWAPs considered | item	5
Conversion price, Number of trading days | D	20
Base conversion price | $ / shares	$ 0.926
Number of days written notice	3 days
Percentage of outstanding principal amount payable upon conversion in cash	105.00%
Percentage of outstanding principal that the Investor has an option to convert to common stock	103.00%
Percentage of outstanding principal that the Investor has an option to redeem	103.00%
Period after the Conversion Trigger Date, that the Investor may convert only upto to an aggregate of $250,000 in outstanding principal amount	9 months
Aggregate outstanding principal amount that can be converted, after the Conversion Trigger Date within nine-month period	$ 250,000

XML

Borrowings - Payroll Protection Program Note Agreement (Details) - Payroll Protection Program Note Agreement - USD ($)	3 Months Ended
	Sep. 30, 2021	May 03, 2020
Borrowings
Principal amount of debt		$ 847,000
Debt instrument, interest rate stated percentage		1.00%
Gain on extinguishment of debt	$ 859,000

XML

Fair Value Measurements - Financial assets and liabilities measured at fair value on recurring basis (Details) - Recurring - Significant unobservable inputs (Level 3) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Liabilities:
Derivative liability	$ 286
Warrant liability	719	$ 8
Total	$ 1,005

XML

Fair Value Measurements - Summary of changes in fair value of the Company's warrant liability and derivative liability (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Summary of changes in fair value of the Company's liabilities
Fair value of the convertible note	$ 3,000,000
Warrant Liability
Summary of changes in fair value of the Company's liabilities
Beginning balance	8
Fair Value at issuance date	985
Change in fair value	(274)
Ending balance	719
Derivative Liability
Summary of changes in fair value of the Company's liabilities
Beginning balance	0
Fair Value at issuance date	286
Ending balance	$ 286

XML

Convertible Preferred Stock and Stockholders' Equity - Activity related to restricted stock award (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Shares
Vested			(204,384)
Non-vested as of September	290,625		290,625
Restricted stock
Shares
Non-vested as of January			728,255
Granted			1,274,900
Vested			(284,299)
Forfeited			(41,372)
Non-vested as of September	1,677,484		1,677,484
Weighted-Average Grant Date Fair Value
Non-vested as of January			$ 3.43
Granted			1.18
Vested			3.07
Forfeited			1.92
Non-vested as of September	$ 1.82		$ 1.82
Restricted stock units | 2020 Stock Incentive Plan
Shares
Non-vested as of January			438,462
Vested	(59,931)	(201,343)	(66,766)	(201,343)
Forfeited			(10,069)
Non-vested as of September	361,627		361,627
Weighted-Average Grant Date Fair Value
Non-vested as of January			$ 2.36
Vested			2.43
Forfeited			2.27
Non-vested as of September	$ 2.35		$ 2.35
Restricted stock units | 2022
Shares
Granted			370,000
Non-vested as of September	370,000		370,000
Weighted-Average Grant Date Fair Value
Granted			$ 0.52
Non-vested as of September	$ 0.52		$ 0.52

XML

Convertible Preferred Stock and Stockholders' Equity - Warrants for common stock outstanding and exercisable (Details) - Warrant [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Exercise Price Range One
Convertible Preferred Stock and Stockholders' Equity
Warrants Outstanding	3,938,571	3,537,965
Weighted Average Remaining Life (years)	2 years 11 months 1 day	3 years 6 months 21 days
Warrants Exercisable	3,734,187	3,527,965
Exercise Price Range One | Minimum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 1.00	$ 1.52
Exercise Price Range One | Maximum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 2.61	$ 3.90
Exercise Price Range Two
Convertible Preferred Stock and Stockholders' Equity
Warrants Outstanding	2,446,219	588,308
Weighted Average Remaining Life (years)	2 years 10 months 17 days	4 years 3 days
Warrants Exercisable	2,446,219	588,308
Exercise Price Range Two | Minimum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 3.00	$ 4.20
Exercise Price Range Two | Maximum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 4.46	$ 9.80
Exercise Price Range Three
Convertible Preferred Stock and Stockholders' Equity
Warrants Outstanding	32,889	92,963
Weighted Average Remaining Life (years)	2 years 4 months 28 days	1 year 21 days
Warrants Exercisable	32,889	92,963
Exercise Price Range Three | Minimum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 6.40	$ 15.80
Exercise Price Range Three | Maximum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 9.80	$ 17.50
Exercise Price Range Four
Convertible Preferred Stock and Stockholders' Equity
Warrants Outstanding	92,940	222,807
Weighted Average Remaining Life (years)	6 months	1 year 1 month 17 days
Warrants Exercisable	92,940	222,807
Exercise Price Range Four | Minimum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 15.80	$ 24.80
Exercise Price Range Four | Maximum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 17.50	$ 99.00
Exercise Price Range Five
Convertible Preferred Stock and Stockholders' Equity
Warrants Outstanding	192,183	47,678
Weighted Average Remaining Life (years)	6 months 3 days	10 months 24 days
Warrants Exercisable	192,183	47,678
Exercise Price Range Five | Minimum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 24.80	$ 108.00
Exercise Price Range Five | Maximum
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	125.00	125.00
Exercise Price Range Six
Convertible Preferred Stock and Stockholders' Equity
Exercise Price	$ 4.39	$ 7.26
Warrants Outstanding	6,702,802	4,489,721
Weighted Average Remaining Life (years)	3 years 5 months 19 days	3 years 5 months 8 days
Warrants Exercisable	6,498,418	4,479,721

XML

Convertible Preferred Stock and Stockholders' Equity - Warrants for shares of common stock (Details)		1 Months Ended				3 Months Ended			9 Months Ended	12 Months Ended
	Aug. 15, 2022 USD ($)	Aug. 31, 2022 shares	Dec. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) Y $ / shares shares	Jan. 31, 2021 USD ($) Y $ / shares shares	Sep. 30, 2021 shares	Jun. 30, 2021 USD ($) Y $ / shares shares	Mar. 31, 2021 shares	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 $ / shares shares	Apr. 18, 2019 shares
Convertible Preferred Stock and Stockholders' Equity
Fair value of warrant | $									$ 719,000
Dividend rate									8.00%	8.00%
Gross proceeds | $	$ 3,000,000
Number of stock released									204,384
Lippert Heishorn Associates Inc
Convertible Preferred Stock and Stockholders' Equity
Exercise price of warrants | $ / shares			$ 1.52							$ 1.52
Common stock price | $ / shares			$ 1.49							1.49
Proceeds from warrant exercises | $			$ 21,000
Issuance of common stock			25,000
Design LLC
Convertible Preferred Stock and Stockholders' Equity
Exercise price of warrants | $ / shares			$ 1.52							$ 1.52
Proceeds from warrant exercises | $			$ 12,000
Issuance of common stock			15,000
Walsh
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued											12,756
Common stock
Convertible Preferred Stock and Stockholders' Equity
Issuance of common stock upon warrant exchanged						19,000	1,360,244	2,086,251
Warrant | Common stock
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued				1,000,000			1,000,000
Exercise price of warrants | $ / shares				$ 4.46			$ 4.46
Fair value of warrant | $				$ 579,000			$ 579,000
Common stock price | $ / shares				$ 4.50			$ 4.50
Warrants to purchase shares of common stock for cash				250,000
Warrant term				5 years			5 years
Gross proceeds | $				$ 2,300,000
Warrant | January 2021
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued					1,221,675
Exercise price of warrants | $ / shares					$ 4.20
Fair value of warrant | $					$ 567,000
Common stock price | $ / shares					$ 3.85
Proceeds from warrant exercises | $					$ 2,900,000
Warrants to purchase shares of common stock for cash					305,419
Warrant term					5 years
April 2020 Maxim Warrant
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued			10,000						10,000	10,000
Common stock price | $ / shares			$ 15.80						$ 15.80	$ 15.80
Combined shares price | $ / shares									$ 0.20	$ 0.20
Issuance of common stock upon warrant exchanged									20,722	20,722
Dividend Yield | Warrant
Convertible Preferred Stock and Stockholders' Equity
Measurement input				0.0			0.0
Dividend Yield | Warrant | January 2021
Convertible Preferred Stock and Stockholders' Equity
Measurement input					0.0
Volatility | Warrant
Convertible Preferred Stock and Stockholders' Equity
Measurement input				60.7			60.7
Volatility | Warrant | January 2021
Convertible Preferred Stock and Stockholders' Equity
Measurement input					60.1
Risk-free rate of interest | Warrant
Convertible Preferred Stock and Stockholders' Equity
Measurement input				0.77			0.77
Risk-free rate of interest | Warrant | January 2021
Convertible Preferred Stock and Stockholders' Equity
Measurement input | $					0.45
Term (Years) | Warrant
Convertible Preferred Stock and Stockholders' Equity
Measurement input | Y				5.0			5.0
Term (Years) | Warrant | January 2021
Convertible Preferred Stock and Stockholders' Equity
Measurement input | Y					5.0
Series A Preferred Stock
Convertible Preferred Stock and Stockholders' Equity
Shares issued		0							0
Dividend rate		8.00%							8.00%

XML

Convertible Preferred Stock and Stockholders' Equity (Details)								1 Months Ended				3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 19, 2022 shares	Sep. 13, 2022 USD ($)	Aug. 15, 2022 USD ($) $ / shares shares	Dec. 30, 2021 USD ($)	Sep. 13, 2021 USD ($) D shares	Jun. 04, 2021 USD ($) shares	Apr. 18, 2019 USD ($) $ / shares shares	Aug. 31, 2022 shares	Dec. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Jan. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2021 $ / shares shares	Mar. 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 $ / shares shares	Aug. 24, 2022 USD ($)	Aug. 19, 2022 shares	Jun. 21, 2022 shares
Convertible Preferred Stock and Stockholders' Equity
Dividend rate																8.00%		8.00%
Number of shares authorized									1,250,000			0				0		1,250,000
Preferred stock outstanding									0			0				0		0
Number of stock released																204,384
Stock-based compensation | $												$ 63,000				$ 191,000
Shares unvested												290,625				290,625
Gross proceeds | $			$ 3,000,000
Registered direct offering, net of issuance costs | $													$ 9,026,000
Change in fair value of warrant liability | $												$ 274,000	$ 0			$ 274,000	$ 0
Common Shares [Member]
Convertible Preferred Stock and Stockholders' Equity
Issuance of common stock upon warrant exchanged													19,000	1,360,244	2,086,251
Registered direct offering, net of issuance costs | $													$ 1,000
Aggregate shares sold													2,500,000
Common Shares [Member] | Warrant
Convertible Preferred Stock and Stockholders' Equity
Share Price | $ / shares										$ 4.50				$ 4.50
Number of common stock shares called by warrants issued										1,000,000				1,000,000
Exercise price of warrants | $ / shares										$ 4.46				$ 4.46
Warrant term										5 years				5 years
Gross proceeds | $										$ 2,300,000
January 2021 | Warrant
Convertible Preferred Stock and Stockholders' Equity
Share Price | $ / shares											$ 3.85
Number of common stock shares called by warrants issued											1,221,675
Exercise price of warrants | $ / shares											$ 4.20
Warrant term											5 years
Proceeds from warrant exercises | $											$ 2,900,000
Vesting upon achievement of first milestone
Convertible Preferred Stock and Stockholders' Equity
Market capitalization | $					$ 75,000,000														$ 50,000,000
Vesting upon achievement of second milestone
Convertible Preferred Stock and Stockholders' Equity
Market capitalization | $					100,000,000														75,000,000
Vesting upon achievement of third milestone
Convertible Preferred Stock and Stockholders' Equity
Market capitalization | $					$ 150,000,000														$ 100,000,000
Restricted stock
Convertible Preferred Stock and Stockholders' Equity
Number of restricted shares granted																1,274,900
Number of stock released																284,299
Shares unvested									728,255			1,677,484				1,677,484		728,255
Unamortized compensation costs | $												$ 2,374,000				$ 2,374,000
Weighted-average period																2 years 2 months 12 days
Carve-Out Plan | Restricted stock
Convertible Preferred Stock and Stockholders' Equity
Aggregate intrinsic value | $															$ 2,000
Number of stock released															352
LTSI
Convertible Preferred Stock and Stockholders' Equity
Maximum shares authorized to issue, percentage												15.00%				15.00%
Percentage of maximum shares issued in a year												8				8
Number of restricted shares granted						0
Number of shares available for grant												1,265,525				1,265,525
LTSI | Restricted stock
Convertible Preferred Stock and Stockholders' Equity
Number of restricted shares granted												61,348	29,064			284,299	29,064
Aggregate intrinsic value | $												$ 37,000	$ 93,000			$ 294,000	$ 93,000
September 2021 Inducement Grant
Convertible Preferred Stock and Stockholders' Equity
Unrecognized tax benefits, interest on income taxes expense | $																$ 504,000
Vesting term																2 years
Number of stock released					232,500
Consecutive days to calculate volume weighted average closing price per share | D					10
September 2021 Inducement Grant | Vest monthly over a period of 36 months
Convertible Preferred Stock and Stockholders' Equity
Vesting term					36 months
Number of stock released					77,500
Value of grant | $					$ 772,000
September 2021 Inducement Grant | Vest upon the achievement of certain company milestones
Convertible Preferred Stock and Stockholders' Equity
Number of stock released					77,500
September 2021 Inducement Grant | Restricted stock
Convertible Preferred Stock and Stockholders' Equity
Number of restricted shares granted					310,000
2020 Stock Incentive Plan | Restricted stock units
Convertible Preferred Stock and Stockholders' Equity
Aggregate intrinsic value | $												$ 43,000	$ 646,000			$ 50,000	$ 646,000
Number of stock released												59,931	201,343			66,766	201,343
Shares unvested									438,462			361,627				361,627		438,462
Unamortized compensation costs | $												$ 451,000				$ 451,000
Weighted-average period																10 months 24 days
2022 | Restricted stock units
Convertible Preferred Stock and Stockholders' Equity
Number of restricted shares granted																370,000
Shares unvested												370,000				370,000
Common stock authorized for issuance under the plan																				500,000	500,000
Number of shares that each RSU represents	1
Shares issued to to employees, directors and consultants	370,000
Unamortized compensation costs | $												$ 191,000				$ 191,000
Weighted-average period																3 years 8 months 12 days
Walsh
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued							12,756
Maxim
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued			194,384
Exercise price of warrants | $ / shares			$ 0.997
Proceeds from warrant exercises | $			$ 91,000
Exercise price | $ / shares			$ 0.77
Dividend rate			0.00%
Volatility rate			80.30%
Risk free interest rate			2.91%
Expected term			5 years
Issuance of common stock			194,384
Maxim | Sales Agreement
Convertible Preferred Stock and Stockholders' Equity
Registered direct offering, net of issuance costs | $				$ 4,500,000
Maxim | 2022 Sales Agreement
Convertible Preferred Stock and Stockholders' Equity
Registered direct offering, net of issuance costs | $		$ 4,000,000
Lippert Heishorn Associates Inc
Convertible Preferred Stock and Stockholders' Equity
Share Price | $ / shares									$ 1.49									$ 1.49
Exercise price of warrants | $ / shares									$ 1.52									1.52
Proceeds from warrant exercises | $									$ 21,000
Dividend rate									0.00%
Volatility rate									67.00%
Risk free interest rate									1.19%
Expected term									5 years
Issuance of common stock									25,000
Design LLC
Convertible Preferred Stock and Stockholders' Equity
Exercise price of warrants | $ / shares									$ 1.52									1.52
Proceeds from warrant exercises | $									$ 12,000
Exercise price | $ / shares									$ 1.49									$ 1.49
Dividend rate									0.00%
Volatility rate									67.00%
Risk free interest rate									1.19%
Expected term									5 years
Issuance of common stock									15,000
Investor [Member]
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued			2,097,022
Exercise price of warrants | $ / shares			$ 0.997
Proceeds from warrant exercises | $			$ 985,000
Exercise price | $ / shares			$ 0.77									$ 0.56				$ 0.56
Dividend rate			0.00%													0.00%
Volatility rate			80.30%													88.30%
Risk free interest rate			2.91%													4.06%
Expected term			5 years
Issuance of common stock			2,097,022
Lisa Walsh
Convertible Preferred Stock and Stockholders' Equity
Number of common stock shares called by warrants issued						187,500
Deemed dividend | $						$ 1,192,000
Series A Preferred Stock
Convertible Preferred Stock and Stockholders' Equity
Dividend rate								8.00%								8.00%
Shares issued								0				0				0
Stated value | $ / shares							$ 4.00
Floor price per share | $ / shares							30.00
Number of shares authorized								1,250,000				0				0
Preferred stock outstanding								0				0				0
Conversion price per share | $ / shares							$ 80.00
Series A Preferred Stock | Minimum
Convertible Preferred Stock and Stockholders' Equity
Proceeds net of issuance cost | $							$ 500,000
Series A Preferred Stock | Maximum
Convertible Preferred Stock and Stockholders' Equity
Proceeds net of issuance cost | $							5,000,000
Series A Preferred Stock | Walsh
Convertible Preferred Stock and Stockholders' Equity
Proceeds net of issuance cost | $							1,000,000
Fair value of embedded derivative liability | $							$ 216,000
Series A Preferred Stock | Lisa Walsh
Convertible Preferred Stock and Stockholders' Equity
Convertible preferred stock issuable						250,000
Series A Preferred Stock | Preferred Investor
Convertible Preferred Stock and Stockholders' Equity
Dividend rate							8.00%
Shares issued							250,000
Par value | $ / shares							$ 0.0001

XML

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Taxes
Provision for income taxes	$ 0	$ 0	$ 2,000	$ 2,000
Effective tax rate			0.00%	(0.02%)

XML

Commitments and Contingencies (Details) - USD ($)	1 Months Ended
	Aug. 31, 2020	Jul. 31, 2018	Sep. 30, 2022	Sep. 01, 2022	Dec. 31, 2021
Commitments and Contingencies
Initial lease term					12 months
Term of capital lease	36 months
Lease expiration date		Jan. 01, 2024
Aggregate Retention Plan bonus amounts for all Managers				$ 1,250,000
Accrual for bonus under the Retention Plan			$ 0

XML

Commitments and Contingencies - Schedule of lease assets and lease liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jan. 01, 2022
Commitments and Contingencies
Operating lease liabilities, current	$ 142
Office space under a non-cancellable operating lease
Commitments and Contingencies
Operating lease right-of-use asset	143	$ 212
Operating lease liabilities, current	142	148
Operating lease liabilities, non-current	$ 74	$ 179
Operating lease liabilities, current [Extensible Enumeration]	Accrued Liabilities, Current
Operating lease liabilities, non-current [Extensible Enumeration]	Other liabilities

XML

Commitments and Contingencies - Schedule of lease costs (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Commitments and Contingencies
Operating lease cost	$ 28	$ 74
Short-term lease cost	9	38
Total lease cost	$ 37	$ 112

XML

Commitments and Contingencies - Schedule of maturity of operating lease liabilities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Commitments and Contingencies
2022 (remaining 3 months)	$ 28
2023	173
2024	29
Total lease payments	230
Less: Interest	(14)
Present value of lease liabilities	$ 216
Present value of lease liabilities [Extensible Enumeration]	us-gaap:OtherLiabilities

XML

Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Details)	Sep. 30, 2022
Commitments and Contingencies
Weighted-average remaining lease term (in years)	1 year 4 months 24 days
Weighted-average discount rate	8.00%

XML

Commitments and Contingencies - Schedule of Supplemental cash flow information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Commitments and Contingencies
Operating cash outflows from operating leases	$ 42	$ 125

XML

Commitments and Contingencies - Schedule of Future minimum lease commitments for finance lease (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Commitments and Contingencies
Year ending December 31, 2022 (remaining 3 months)	$ 7
Year ending December 31, 2023	15
Total minimum lease payments	22
Less: Amounts representing interest	(1)
Present value of finance lease obligations	21
Less: Current portion of finance lease liabilities	$ 21
Less: Current portion of finance lease liabilities [Extensible Enumeration]	Accrued Liabilities, Current
Other liabilities [Extensible Enumeration]	Other liabilities

XML

Related Parties (Details) - USD ($)		3 Months Ended		9 Months Ended
	Jan. 15, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Related Parties
Common stock, shares issued	40,000
Meriwether Accelerators
Related Parties
Professional and contract services expense	$ 7,500
Common stock, shares issued	10,000
Other expenses		$ 8,000		$ 45,000
Warrant | Meriwether Accelerators
Related Parties
Ownership percentage		1.00%		1.00%		1.00%
Helge Kristensen | Warrant
Related Parties
Ownership percentage		1.00%		1.00%		1.00%
Hansong Technology
Related Parties
Revenue from related parties		$ 146,000	$ 263,000	$ 337,000	$ 496,000
Payments for purchases		516,000	309,000	1,306,000	962,000
Purchase of wireless audio speaker systems from related party		908,000	96,000	1,367,000	854,000
Due to related party		851,000	96,000	851,000	96,000
Due from related party		146,000	129,000	146,000	129,000
Hansong Technology | Sales To Related Party
Related Parties
Payments for purchases		$ 191,000	$ 333,000	$ 191,000	$ 380,000

XML

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) segment	Sep. 30, 2021 USD ($)
Segment Information
Number of operating segments | segment			1
Net revenue	$ 937	$ 1,807	$ 2,449	$ 4,541
North America
Segment Information
Net revenue	244	166	681	710
Europe
Segment Information
Net revenue	62	162	411	403
Asia Pacific
Segment Information
Net revenue	$ 631	$ 1,479	$ 1,357	$ 3,428